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Consensus opinion suggests that apoptosis occurs when the intracellular redox potential 
reaches its oxidative range, i.e. when the balance between oxidants and reductants is 
disturbed. An understanding of the links between redox potential and the induction of 
apoptosis in cells could improve our understanding of the process and help to predict 
therapeutic responses.  
This study investigates the changes in redox potential at distinct stages of apoptosis 
induced in the human cervical cancer cell line, HeLa. Stages of the apoptotic process 
were defined by loss of mitochondrial membrane polarisation (ΔΨm), membrane 
phosphatidyl serine exposure, caspase-3 activation, and nuclear fragmentation. To 
measure real-time redox potential change in apoptotic cells two independent methods 
were used:  (1) expression of redox-responsive green fluorescent protein (roGFP2) 
measured by flow cytometry and (2) redox-responsive nanosensors detected by surface 
enhanced Raman spectroscopy (SERS).  
roGFP2 measurements showed that HeLa cells demonstrate a shift towards an oxidative 
redox state during the later stages of apoptosis and this was preceded by loss of ΔΨm. 
The relationship between these two events was investigated by transient inhibition of 
mitochondrial permeability transition pore opening using the inhibitor bongkrekic acid 
(BKA) pre-treatment.   
At the cell population level, transient exclusion of the mitochondrial contribution 
delayed two key events of apoptosis in the first two hours measured by nuclear 
fragmentation and loss of ΔΨm. However, BKA treatment did not affect redox 
potential, reported by roGFP2, when compared with controls. Therefore, this suggests 
that mitochondria do not contribute towards the overall redox potential change in 
apoptosis. 
To gain insight into the significance of redox change at the earliest stages of apoptosis, 
single cell studies were performed. SERS, employing simultaneous redox potential and 
intracellular pH measurements using two synthetic nanosensors AQ-NS and MBA-NS, 
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showed that BKA pre-treatment resulted in increased alkalinity and the cells were 
consequently protected from induction of apoptosis in the first thirty minutes of the 
kinase inhibitor staurosporine treatment.  
Measurements with SERS nanosensors allowed for adjustment for pH, which provides a 
clearer insight into redox potential dynamics, with consideration of the environment, 
and accurate quantitative assessment of redox at early stages of apoptosis. 
Together these data suggest that while roGFP2 is a valid method to use at a population 
level, SERS is a more sensitive method for measuring the redox potential of the cell at 






Cancer is characterised by established hallmarks including abnormal cell growth, 
altered metabolism, and evasion of apoptosis. Apoptosis is a form of programmed cell 
death, meaning that it is an active process, which is characterised by a sequence of 
subcellular events eventually leading to cell death. Many cancer treatments aim to 
induce cancer cell apoptosis in order to halt or reverse tumour growth. However, our 
understanding of some of the apoptosis-associated events is incomplete. One of these 
events is a change in the so-called redox potential, which defines the chemical state of 
molecules within the cell. Understanding the dynamics of the redox-potential 
throughout the process of cell death could help define new treatment strategies. 
The aim of this study was to characterise the intracellular redox potential change 
throughout apoptosis and relate it to other, well-defined events happening during this 
process. However, current redox potential detection methods are limited in their 
specificity and sensitivity, measuring only one out of many redox couples. With recent 
advancements in nanotechnology, our group developed a range of redox sensitive 
nanosensors. These sensors are able to pick up changes in the redox potential of all 
redox couples present within the cells, giving a better measurement of the overall redox 
potential than previous technologies. 
Using these nanosensors, which proved non-toxic to the cell type used in this study, the 
time course of redox potential and pH changes following the induction of apoptosis 
could be assessed. It could also be established that the modulation of another subcellular 
event associated with cell death beneficially altered the overall redox potential and 
coincided with a delay in cell death. Whether changes in the redox potential themselves 
are able to drive or inhibit the progression of apoptosis, remains to be determined. 
However, the nanosensors tested in this thesis offer the ideal tool for further studies in 
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Chapter 1  
Introduction 
 
1.1 Role of redox potential in cellular homeostasis 
 
Cellular homeostasis is maintained by a range of processes that rely on the energy 
that comes from electron transfer between oxidizable organic molecules to oxygen. 
Despite the fact that oxygen is essential for living, it is highly reactive and its 
interactions with biological molecules can give rise to products that, if in excess, 
have a deleterious effect on the body. A delicate balance of forces between anti-
oxidants and oxidants is essential for maintaining the health of the cell. 
A range of processes rely on the energy that comes from the electron transfer 
between redox couples. This movement of electrons is predetermined by the specific 
combination of donors and acceptors of a reaction. The redox potential of the 
biological environment is therefore defined as a measure of the oxidative and 
reductive ability of the environment and is measured in millivolts (mV). 
Redox regulation of biological systems is of interest since hypoxia or oxidative 
damage plays an important role in normal physiology as well as a role in diseases 
such as cancer [1], cystic fibrosis [2]  atherosclerosis [3], or ischaemic and 
reperfusion damage [4].  
1.2 Intracellular redox state and cellular processes 
Oxidative damage can be caused by reactive oxygen species (ROS) (e.g. superoxide 
anion (O ), hydrogen peroxide (H2O2) and hydroxyl radical (·OH) produced in the 
extracellular environment or internally as byproducts of metabolic pathways (Figures 
1.1 and 1.2). Not all ROS act in the same way, and their damaging or messaging 
properties may solely depend on the quantity within the intracellular environment 
and therefore they may have a dual role in the fate of the cell. 
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In small quantities these molecules serve as messengers that can reversibly modify 
proteins and therefore regulate their activity. However, if in excess their toxicity lies 
in their powerful oxidising properties [5, 6] (Figure 1.1).  One of the examples of 
oxidative stress is lipid peroxidation of fatty acids present in cellular membranes. 
Reaction between unsaturated fatty acid and free radical occurs by a radical 
capturing a hydrogen moienty from an unsaturated carbon to form water. An 
unpaired electron is prone to capture an oxygen resulting in peroxy radical formation. 
It is important therefore to maintain an equitable balance between oxidants and 
antioxidants (Figure 1.2).  
 
Figure 1.1 Redox regulation of cellular systems. Scavengers and pro-oxidants 
control of protein function directly by thiol regulation of key proteins regulating 
cellular responses [7]. Scavenger redox couples: glutathione and glutathione 
disulphide (GSH/GSSG); reduced and oxidised thioredoxin protein (Trx-(SH)2./Trx-
S2. 
 
The redox system comprises of redox couples that are the driving force for the 
maintenance of the redox status within the cell. These include regulation of 
GSH/GSSG, thioredoxins, NAD(P)H/NAD(P)+ and ROS. Quantitatively, the redox 
environment can be described as follows [8]: 
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where Ei is the half wave potential for a redox couple and [reduced species]i is the 
concentration of the reduced species in the environment. The flow of electrons 
between species is related to the Gibbs change in free energy (ΔG°) by   
∆𝐺° = −𝑛𝐹𝐸   
Compounds involved can donate electrons, so called reductants, and oxidants can 
easily take up electrons thus oxidising other compounds. It has been problematic to 
quantify the values of intracellular oxidised and reduced species in biological 
systems as redox couples are never in equilibrium as this would indicate that the 
system is non-viable. For example, the ratio of the concentration of reduced NADPH 
to oxidised NADP+ is 100:1 while for NADH:NAD+, with similar redox potential, 
the ratio is 30:70 [8].  
The oxidised and reduced forms of the same molecule form redox couples (Table 
1.1). Redox reactions are often a consecutive chain of interaction of redox active 
moieties. A list of biological redox potentials is shown in Table 1.1. 
Redox couple Standard redox potential 
NADH/NAD+ -320 mV 
NADPH/NADP+ -324 mV 
Trx(SH)2/TrxSS -292 mV 
GSH/GSSG -240 mV 




1.2.1 Nernst Equation 
The redox potential of the cell can be quantified by using the Nernst equation 
(Equation 1). This is widely used in electrochemistry to define the potential of the 
half-cell under non-standard conditions,  




Equation 1: Nernst equation  
where E is a potential measured under standard conditions (298 K (25 oC), 1 M 
concentration of substrates and pH 0) in (V); Eθ - is the standard half wave potential 
for [9, 10] a particular redox couple (V); R - is the universal gas constant 
(R=8.314472(15) JK-1 mol-1); T - is the temperature (K); n – is the number of 
electrons involved in the reaction; F – is the Faraday constant (9.65(24)x104 C mol-1);  
Q is the ratio of products to substrates of the reaction. 
Redox couples are linked to each other and therefore the redox state of the 
environment is a reflection of the status of these couples and this defines an overall 
redox potential.  For example, the ratio of the oxidised to reduced form of 
glutathione allows definition of the environment as reducing or oxidising. The 
standard redox potential at pH 7 for glutathione is estimated to be -240 mV [8][8] at 
298.15 K (25 oC) and the change in redox potential would be as follows:  
GSSG + 2H+ + 2e–  ⇌ 2 GSH 






)  mV 
To apply the Nernst equation in biological systems, one has to adjust the temperature 
value, normally to 310 K (37 oC) and the pH to 7.2, so-called physiological 
conditions. However, pH may vary between different subcellular compartments for 
example the mitochondria or cytoplasm, and thus it is important to measure the pH 
and redox potential simultaneously throughout biological processes and different 
compartments. When applied to biological systems, measuring electrical activity by 
using the ratio of oxidised to reduced species under physiological conditions, of the 
local environment assumes a pH of 7.2 [8].  
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1.2.2 Antioxidant system 
Cells have a range of molecules that act as scavengers for harmful radicals and these 
are in the form of antioxidant enzymes (e.g. superoxide dismutase, catalases, 
peroxidases) [6] or non-enzymatic antioxidants: glutathione, or ubiquitous proteins 
such as thioredoxins. The main role of these molecules is to convert superoxide to 
hydrogen peroxide and ultimately neutralise it to water (Figure 1.2).  
 
Figure 1.2 Mechanisms of ROS generation and detoxification. Modified from [6]. 
Two compartments are shown here: Cytosol and mitochondria. Generated in the 
inner membrane of the mitochondria as a by-product, superoxide, is released into the 
mitochondrial matrix or cytosol via the mitochondrial permeability transition pore 
(MPTP). Alternatively, superoxide is also generated through NADPH oxidases 
(NOX) in response to growth factor receptors. Superoxide dismutase enzymes (SOD) 
reduce superoxide to hydrogen peroxide. Both hydrogen peroxide and superoxide 
radical contribute to cellular signalling. However, if in excess it is balanced out by 
the antioxidant system in the cytosol (including catalase, glutathione peroxidase, 




The superoxide radical is one of the electron transport chain byproducts at the inner 
mitochondrial membrane, which is then released into the mitochondrial matrix or 
cytosol. It is usually reduced to hydrogen peroxide (H2O2) by superoxide dismutases. 
It can also be generated through NADPH oxidases (NOX) in the cytosol. It is 
reduced to H2O2 by cytosolic systems serving as antioxidants (peroxiredoxins (Prx); 
glutathione peroxidase (GPX), and catalase). In low concentrations it contributes to 
intracellular signalling [11]. 
1.2.3 Glutathione/glutathione disulfide 
Glutathione (gamma-glutamyl-cysteinyl-glycine) is the most abundant non-protein 
thiol redox buffer in the cell [12] . Glutathione is a tripeptide, synthesised from 
glutamate and cysteine by gamma-glutamylcysteine synthetase. It results in the 
formation of gamma-glutamylcysteine and glycine is added by GSH synthetase.  
Depletion of free cysteines or gamma glutamyl cysteine sensitises cells to cell death 
[4, 13]. Studies on several cancer types in leukaemia [14], lymphoma [15]and hepatic 
cancers [16] have reported that these cells have higher intracellular GSH content than 
healthy cells. 
It can be found in two forms: (1) reduced (GSH), a monomer with the free thiol 
group, and (2) oxidised (GSSG) dimer formed via a disulfide bond (Figure 1.3), 
however its innate form is reduced and acts as an electron donor. Glutathione 
therefore acts as a guard to maintain the reduced intracellular environment. Depletion 
of the intracellular GSH pool has been shown to induce cell death pathways[17].  
Glutathione can become oxidised, forming intermolecular disulfide bonds, thus 
protecting the cell from oxidative and nitrosative stress. Its concentration ranges 
from 1 to 11 mM [18].  The ratio of the oxidised to reduced form of glutathione 
allows definition of the environment as reducing or oxidising.  
Glutathione is a reserve form of cysteine for the cell [19], which plays a crucial role 
in regulatory aspects. It is a major intracellular reducing agent and free radical 







Figure 1.3 Glutathione (A) and glutathione disulfide (B).  
In addition to its thiol-redox control, glutathione contributes to iron-sulphur cluster 
(ISC) maturation. Kumar et al. challenged the field by reporting that during redox 
stress high glutathione levels is linked to its involvement in iron metabolism, and that 
the thiol-redox maintenance is dependent on iron metabolism [22]. 
Glutathione is soluble and as a redox-wise regulatory buffer, its redox state is 
compartmentalised between cell structures such as the cytoplasm, mitochondria, 
endoplasmic reticulum and nucleus[23]. Glutathione is actively transferred by groups 
of enzymes called glutathione S-transferases (GST). The companion redox systems 
to GSH/GSSG are thioredoxins [12, 24].  
1.2.3.1 Thioredoxins 
Thioredoxins are small proteins that have cysteine residues in a sequence, Cys-Gly-
Pro-Cys at a conserved active site at the N-terminus of an α helix near the central 
portion of a β sheet [25][23]. Upon oxidation these cysteines form intramolecular 
disulfide bonds. Thioredoxin reductase enzymes transform oxidised thioredoxin back 




Figure 1.4: Crystal Structure of human Thioredoxin-2 . PDB ID 1THX. B. 
NADPH-dependent renewal of GSH by glutathione reduxtase GR, Grx) and by 
Thioredoxin (reduxed form TrxSH2 and oxidised TrxS) and Thioredoxin reductase 
(Trx).  
1.2.3.2 Nicotinamide adenine dinucleotide and nicotinamide 
adenine dinucleotide phosphate 
The glutathione buffer system is tightly connected to thioredoxin proteins by a 
common substrate nicotinamide adenine dinucleotide (NAD+/NADH) and 
nicotinamide adenine dinucleotide phosphate (NADP+/NADPH). This provides a 
reductive driving force, which enables it to act effectively as a scavenger of free 
radicals, ROS, and reactive nitrogen species (RNS). NADPH is a derivative of 
NADH and is necessary in the phosphogluconate pathway (secondary route for 
glucose oxidation). NADPH functions as an electron donor in reductive reactions, 
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while NAD+ plays a major role in oxidative reactions and is an electron acceptor. 
These two redox couples are not in equilibrium with each other to allow functioning 
of these couples [26].  
1.3 Redox compartmentalisation and regulation of cellular 
processes within the cell 
Steady-state redox potentials differ between cell compartments, reflecting local 
functions. For example, mitochondria are structures that maintain one of the most 
reducing environments in the cell [26]. Mitochondria are the primary site of ROS 
generation in the cell [27] (Figure 1.5). They produce free electrons via the citric acid 
cycle which reduces NAD+ to NADH and this serves as an electron donor in the 
mitochondrial electron transport chain to release ATP into the cytoplasm.  
 
Figure 1.5 A representation of mitochondria and processes involved in the 
energy production (enzymes of the tricarboxylic acid (TCA) cycle and oxidative 
phosphorylation (OXPHOS) and its byproducts ROS.  
The cytosol is both structurally and functionally important as typically most redox 
couples are found here, serving as buffering systems for the organelles. Cytoplasmic 
redox potential determined from GSH/GSSG couples varies between -260 mV              
to -170 mV, depending on the activity of the cell [28]. Redox potentials for common 
couples among different organelles are given in Table 1.2. Studies attempted to 
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distinguish potentials of those couples, however, the values are mostly from studies 
in which cell lysates were used for measuring the concentration of particular couples, 
therefore this may not reflect a true redox potential status of the intracellular 
environment of the cell [26].  
On the opposite scale of redox potentials, due to the function, the endoplasmic 
reticulum maintains a fairly oxidizing environment to provide milieu favouring 
disulfide formation to ensure correct folding of proteins [29]. 
Table 1.2: Distributions of redox couples and their steady state potentials (mV) 
in different compartments of the cell. Adapted from [26]. Adapted from Kemp et 
al. Steady-state redox potentials are said to vary between cell compartments. From 
various studies on GSH/GSSG in the cytoplasm, it has been concluded that reductive 
potential range promotes proliferation and are more reducing to ones of non-
proliferating cells. Due to a loss of GSH cell’s environment becomes more oxidative. 
It has been also shown that cytoplasmic Trx-1 is more reduced than GSH; however it 
becomes oxidised at the terminal stages of apoptosis. 
 
The current consensus is that an individual cell has five choices: to divide, 
differentiate, undergo senescence, commit suicide or remain unchanged [30]. Each 
one of these choices is crucial for the maintenance of tissue homeostasis. Reactive 
oxygen species are capable of damaging all groups of biological macromolecules 
[31]. However, in recent years it has become apparent that the redox status of certain 
molecules contributes towards signalling of various cellular responses from 
proliferation, through differentiation, to cell death [32].  
It has been shown that when cells are in a reductive environment, such as a hypoxic 
stem cell niche, the cells are mostly in a proliferative state (in active cell cycle); cells 
in a normoxic environment tend to initiate pathways which promote differentiation. 
 Mitochondrion Cytoplasm Nucleus Endoplasmic 
Reticulum 
GSH/GSSG -300 -260 to -170  -150 
Trx1(SH)2/SS  -280 -300  
NADPH/NADP+ -405 -393   
NADH/NAD+  -250   
CySH/CySS -360 -160   
11 
 
In line with this, a more oxidative environment promotes cell death (Figure 1.6) [8, 
32]. However, the levels of partial oxygen pressure (pO2) may differ between 
tissues, hence influencing different redox potential and promoting different cell 
behaviour.  
 
Figure 1.6 Redox environment and switching status of activity. A visual 
representation of interplay between pO2, redox potential and cellular fate. More 
reductive environment in hypoxic regions of the tissue promotes proliferation, 
progressing though to normoxia promoting differentiation of cells, though to 
controlled oxidative range of redox potentials initiating single cell demise or 
multicellular uncontrolled response – necrosis. Modified from [8]. 
 
Changes of the reduction potential of the intracellular environment is assumed to 
correlate with the biological status of the cell and the pO2 of the tissues [8, 33]. 
Reductive potentials in hypoxic regions promote proliferation, normoxic regions – 
differentiation, while more oxidative range promotes apoptosis. This hypotesis can 
be used to help understanding the redox biochemistry that results from oxidative 
stress (Figure 1.7). A need for quantitatively measure biology is hypothesised to 
provide an understanding of the cellular mechanisms associated with mechanisms 
directing cell signalling that are quintessential to cellular fate.  
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Although, consistent with the above evidence, the redox potential has been reported 
to play a role in apoptotic events, there are differences in opinion regarding the 
relationships between the molecular events which determine the redox potential and 
those which result in apoptosis [34]. 
 
Figure 1.7 Redox regulation versus oxidative stress. A. Redox regulation of 
proteins is reversible and only appears at specific sites of regulatory proteins 
changing their activity in a reversible manner. As example, such specific change in 
stabilisation may happen through S-nitrosylation of HIF-1a subunit, which causes the 
stabilisation of the subunit and further interaction with HIF-1b subunit [35].  Post-
translational S-glutathionylation occurs through the reversible addition of glutathione 
to cysteines in target proteins, where the modification alters molecular mass, charge, 
structure, and function. B. Oxidative stress, in contrast, is reported to cause 
irreversible, uncontrolled changes in macromolecules leading to permanent loss of 
cellular function and eventually resulting in cell death. Modified from [34]. 
 
ROS and GSH/GSSG couple can regulate protein activity by interacting with 
protein-thiols [34]. Therefore the redox potential of the environment, through 
thiol/disulfide switching, is driving the redox status of different proteins within the 
cellular pathways involved in the fate of the cell.  
1.4 Oxidative stress and cell death 
Vogt is acknowledged to have first described the principles of the morphological 
features of apoptosis in 1842. The term apoptosis was first used by Kerr et al. in 
1972 after observation of the process in various tissues. The Greek translation is 
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from apo ‘from’ + ptōsis ‘falling, a fall’ [36]. Unlike necrosis, which is an 
uncontrolled cell death of multiple cells in one region, apoptosis has a sequence of 
pathways that is activated upon intrinsic or extrinsic stimuli.  
Apoptosis is a programmed cell death, which is necessary in development and 
homeostatic maintenance of multicellular organisms [36]. In normal tissues of 
multicellular organisms, apoptosis is essential for the development (e.g. mammary 
gland involution) [37] and homeostasis (e.g. epithelial cells after wearing). It is also a 
defence mechanism against mutations or in immunity[37, 38].  
Apoptosis can be triggered by many physiological and pathological stimuli, but the 
conditions which induce apoptosis can vary between cell types [37]. Despite this, 
apoptotic events in different cell types and even in cells from different species share 
common morphological hallmarks.  
Cells in early apoptosis exhibit shrinkage and pyknosis (nuclear chromatin 
condensation). As a consequence of the shrinkage, caused by Na+ influx to the cell, 
organelles within the cell are clustered within the reduced volume of the cell [39]. 
Later on in apoptosis irregular membrane blebbing occurs and, as a consequence, 
development of apoptotic bodies takes place. These apoptotic bodies may contain 
fragments of cellular compartments and may also serve as ‘eat me’ signals to 
immune cells[38]. During later stages of apoptosis further chromatin condensation is 





Figure 1.8  A schematic illustration of the apoptotic process supplemented with 
electrion micrographs showing HeLa cell non-apoptotic (in A) and dead cell 
which has undergone (D.) staurosporine-induced apoptosis. Apoptotic cells are 
characterised by shrinkage and condensation of genetic material (green nucleus). 
Breakdown of the cytoskeleton (beige oval) gives rise to membrane blebbing and 
apoptotic bodies. Mitochondria (pink small ovals) and endoplasmic reticulum (blue 
banana-shaped structures) are exemplar organelles undergoing structural change 





The aforementioned characteristics are a consequence of an organised series of 
biochemical events. These happen in a distinct sequence: 
a. initiation phase induced by either external or internal signals;  
b. effector phase, where the cell ‘decides’ to either undergo  
senescence (a slow deterioration) or die;  
c. execution phase, where cells are fully committed to cell death and 
 morphological features are observed.  
An apoptotic cell produces a soluble or membrane bound ‘find me signal’ in the form 
of ATP, lysophosphatidylcholine, fractalkine/CX3CL1 [40], which attracts 
phagocytes, enabling removal of the cell from the system.  
Apoptosis is said to occur when the redox potential reaches its ‘oxidative range’ i.e. 
when the balance between free radicals and scavengers (antioxidants) is disturbed. 
Distinct cysteine residues of the proteins which are involved in the apoptotic process 
are being oxidised which in turn activates them (Figure 1.8). Previously, Campbell’s 
group has assembled a map of proteins which contribute to apoptosis and includes all 
those that are regulated by the redox status [41].    
Proteins regulated by the redox potential are hypothesised to be placed within the 
pathway depending on their redox function. The redox potential of the intracellular 
environment plays an important role in determining the behaviour of the cell also 
through switching on or off the proteins that are sensitive to the redox status of the 
environment such as caspases. On the other hand, the depletion of glutathione, by 
active transport away from cellular structures, has been reported to contribute 
towards oxidative stress [42-44]. These two systems, the protein regulation and the 





Two major pathways can be triggered to commit the cell to programmed cell death, 
referred to as the extrinsic and intrinsic apoptotic pathways [45] (Figure 1.9). It has 
been suggested that these two pathways are separate and only one mode of activation 
can occur in a single cell, however there is evidence that in some cells these two 
pathways do co-exist and cannot be separated [46]. The redox status of cysteines in 
the proteins of these pathways is one of the crucial players for execution of 
apoptosis.  
 
1.4.1 Extrinsic pathway 
1.4.1.1 Role of ligand – receptor binding in transducing signals 
for apoptosis 
Apoptosis can be triggered by a ‘death ligand’ binding to a membrane receptor 
(extrinsically induced cell death). The tumour necrosis factor receptor (TNFR) 
family consist of necrosis factor receptor 1 (TNFR1), CD95 (other names Fas, 
APO1) and TNF-related apoptosis-inducing ligand (TRAIL) receptors. Death ligands 
include TNF, CD95-ligand and TRAIL. All receptors of this superfamily are trimers, 
meaning that they undergo conformational change upon ligand binding and 




Figure 1.9 Intrinsic and extrinsic apoptotic pathways. Extrinsic pathway activated 
by external factors, such as injury, is executed by ligand binding to cell membrane 
receptors, triggering the activation of specific activator caspases. Intrinsic pathway, 
triggered mainly by damage to mitochondria by radiation, toxins, hypoxia causing 
membrane depolarisation and release of pro-apoptotic proteins into the cytosol. The 
two pathways intersect at the activation of executioner caspases (3/7). These 
caspases are commonly used as markers for apoptosis in research investigation prior 
to the typical, morphological changes that occur as a consequence at the later stages 
of apoptotic process. 
 
Upon ligand binding a death receptor exposes a region located in the intracellular 
space (Figure 1.9). For instance in CD95 the intracellular region contains a death 
domain that recruits adapter molecules such as Fas-associated death domain (FADD) 
and procaspase-8 [14, 48][13, 44]. As a consequence a Death-Inducing Signalling 
Complex (DISC) is formed and a death signal is transferred downstream, leading to 
activation of initiation caspases, such as caspase-8. This leads to activation of 
effector caspases-3 and -7 thus initiation of the execution phase of programmed cell 
death [49].  
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However, caspase-8 has also been shown to trigger intrinsic apoptosis by cleaving 
Bid (a member of the B-cell lymphoma protein-2 (Bcl-2) family). The active form of 
Bid, truncated Bid (tBid), translocates to the mitochondrial membrane facilitating the 
release of cytochrome c [50][46]. This leads to activation of caspase-9, which forms 
the apoptosome with other proteins, and ultimately activates executioner caspases-3 
and -7 [51].  
1.4.2 Intrinsic pathway  
The intrinsic pathway (Figure 1.9) can be triggered by genotoxic stress, ionising 
radiation, DNA damage or nutrient deprivation. It is characterised by mitochondrial 
outer membrane permeabilisation (MOMP), which results in the release of soluble 
pro-apoptotic factors including cytochrome c and ROS. This process leads to 
activation of caspases and a reduction of the primary function of the mitochondria, 
energy production [52]. The energy production complexes, including complex I, 
which reside in the mitochondrial membrane, are cleaved by active caspases and 
mitochondrial function is lost. MOMP is mainly regulated by members of the Bcl-2 
family [53].  
1.4.2.1 Oxidative stress due to mitochondrial depolarisation  
Since mitochondria are the principal sites of cellular respiration, they supply energy 
for cell functioning. At the same time they are also the main generators of ROS. This 
makes them an important organelle in the control of redox homeostasis, survival and 
cell death. Mitochondrial membrane permeabilisation has been considered to be an 
event which commits the cell to programmed cell death [54].  
Mitochondria consist of an inner space, the matrix bound by two membranes, the 
outer membrane and the inner membrane, which is greatly folded forming cristae. 
Between the membranes there is a space containing hydrogen ions driven out of the 
inner membrane from the electron-transport-chain, which is formed by a series of 
proteins embedded in the membrane. The accumulation of protons in between the 
outer membrane and inner membrane creates an electrochemical gradient (ΔΨm) 
across the inner membrane (Figure 1.5).  
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Mitochondrial permeabilisation is one of the hallmarks of apoptosis [55]. It has been 
considered as a ‘point of no return’ as once the apoptotic factors, such as cytochrome 
c and Apoptosis Inducing Factor (AIF), have been released, progression of apoptosis 
cannot be arrested. Mitochondrial depolarisation is said to occur stepwise and 
glutathione transport via the outer mitochondrial membrane has been reported 
[56][52]. Bcl-2 family members regulate the permeability of the outer mitochondrial 
membrane and this is regulated by interaction between pro- and anti-apoptotic 
members of the family (Figure 1.10). This interaction of pro-apoptotic Bcl-2 family 
members causes mitochondrial outer membrane permeabilisation (MOMP) which is 
considered to be a point of no return and cells’ commitment to apoptosis. [52, 57-59].  
Reactive oxygen species, changes in intracellular pH and in calcium concentration 
can all contribute to the opening of permeability transition pores in the mitochondrial 
intermembrane space and, as a consequence, have deleterious effects on cellular 
homeostasis. Depolarisation of the inner membrane is lost, water and other solutes 
are able to enter the mitochondria causing its membrane to rupture and, as a 




1.4.3 Bcl-2 protein family 
Bcl-2 is a proto-oncogene that was first discovered in B-cell lymphoma. There are 
many Bcl-2 homologs that have pro- or anti-apoptotic functions (Figure 1.10). Bcl-2 
family members range in size from 20 to 37 kDa.   
a. Anti-apoptotic: Bcl-2 26 kDa; BCL-xL 30 kDa;  
b. Pro-apoptotic: BAX 20 kDa; BAK 25 kDa; BAD 23 kDa; NOXA 10 kDa; PUMA 
23 kDa; tBID 15.4 kDa; BIM 15 kDa; BIK 20 kDa).  
The ratio between pro and anti-apoptotic protein family members determines the fate 
of the cell [60, 61]. In particular, apoptotic signals are sensed by BH3-only factors, 
due to their varied distribution and ability to be activated non-redundantly [62].  
 
Figure 1.10 Bcl-2 family of proteins. Three subclasses have been identified 
depending on their function and structure: anti-apoptotic (Bcl-2, Bcl-xL) 
multidomain pro-apoptotic (BAK, BAX); BH3-domain-only (BAD, NOXA, PUMA, 
tBID);  [62]. BH stands for Bcl-2 homology domain; TM is transmembrane domain 
at the c-terminus.  
It has been reported that Bcl-2 has both pro- and anti-oxidant activity. Hockenbery et 
al. one of the first proposed the model that Bcl-2 functions as an antioxidant thus 
preventing apoptosis. Specifically, in their study, the Bcl-2 protected cells from 
hydrogen peroxide induced cell death, and overexpression of Bcl-2 supressed lipid 
peroxidation [63].  Cells expressing Bcl-2 have an increased pool of GSH and Bcl-2 
knockout mice demonstrate higher oxidative stress. It has been suggested that 
depletion in glutathione influences the decrease in Bcl-2 expression [64, 65]. On the 
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other hand, Bcl-2 increased intracellular ROS levels suggesting that Bcl-2 also acts 
as a pro-oxidant [6].  
The interaction between Bcl-2 family members is selective and this provides an 
important mechanistic basis for triggering pro-apoptotic or pro-survival signalling 
pathways. BAX is expressed in response to stress by a p53-dependent mechanism. In 
highly oxidative environments, p53, through its transcriptional activity, enhances the 
expression of pro-apoptotic, especially BH3-domain-only proteins, and therefore 
promotes the intrinsic apoptotic pathway. [66, 67] 
BAX undergoes a conformational change, dimerises, and penetrates the 
mitochondrial membrane [68]. It has been shown that the depletion of reduced 
glutathione increases the activation of BAX [2]. Consequently, cytochrome c and 
procaspase-9 are released from the mitochondria to the cytoplasm and together with 
APAF-1 form a complex referred to as the apoptosome. This in turn recruits pro-
caspases either directly via CARD-domains or indirectly through involvement of 
additional mediators (CRADD). As a result, the caspase cascade (culminating in 
cleavage of executioner caspases) is activated and the effector phase in the form of 
morphological changes can be observed (Figure 1.9). 
1.4.4 Cytochrome c release from mitochondria 
Cytochrome c is a protein that in its pro-form, apo-cytochrome c, is synthesised in 
the cytosol and transported to the mitochondrial intermembrane space where it is 
converted to holocytochrome c by addition of a haem group by haem lyase. 
Cytochrome c can act as an antioxidant and has ROS scavenging function [69]. Upon 
disruption of the mitochondrial membrane, release of cytochrome c occurs and this 
results in increased levels of superoxide due to interruption of the electron transport 
chain.  
The oxidation state of cytochrome c is regulated by conformational change and this 
is thought to be critical for its binding to apoptotic peptidase activating factor (Apaf-
1)[70], whereas the reduced form of cytochrome c has lower affinity for Apaf-1 and 
thus promotes survival.  Therefore, it is important to distinguish between the 
oxidised and reduced forms of cytochrome c [70] (Figure1.11). Oxidised cytochrome 
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c promotes binding to Apaf-1, allowing for oligomerisation and formation of a 
structure called the apoptosome. [71] The disulfide-mediated interaction with Apaf-1 
results in caspase 9 activation [72].  
 
Figure 1.11 Redox state of cytochrome c and mediation of cell fate. Modified 
from [70] 
It has been shown that ligand binding of cytochrome c does not affect its ability to 
accept or transfer electrons [73]. These have been reported to be independent 
functions as mutation of lysine 72 has been shown to impair apoptosome formation, 
but not activity of cytochrome c in the electron transport chain [74]. 
1.4.5 Caspases 
Both extrinsic and intrinsic pathways require the activation of caspases (cysteine 
proteases cleaving substrates after aspartic acid residues), another critical group of 
proteins orchestrating apoptosis. To date, we distinguish three different subclasses of 
mammalian caspases:  
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 activators of apoptosis (caspases -2, -4, -8, -9),  
 executioners of apoptosis (caspases -3, -6, -7).  
 mediators of the inflammatory response (caspases -1, -5).   
Caspases exist in cells in their pro-form which renders the enzyme inactive [75]. 
Procaspases are built from three regions: pro-domain, large subunit (p20), and small 
subunit (p10). The activation of caspase is initiated either by self-processing or by 
proteolytic processing by other caspases. 
Interestingly, activator caspases are specifically recruited to different sites of cell 
death – caspase-8 is recruited by death-receptor signalling; caspase-2 facilitates 
genotoxic stress-mediated death; caspase-4 is involved in facilitating ER-stress-
mediated death [62]. Most importantly the major executor caspase is caspase-3. The 
cysteine in the caspase active site is sensitive to oxidation or to thiol alkylation. 
Caspase activity can also be reversibly modulated by S-nitrosylation. [76] Circu et 
al. also reported that staurosporine activates caspase-3 independently, to some 
degree, of caspase-8 and -9 and this is also associated with temporal GSH efflux 
from the cell. 
1.5 Cancer and evasion of apoptosis 
One of the fundamental hallmarks of cancer is its ability to evade cell death [77, 78]. 
Some cancer cells are deficient in or express a mutant form of tumour suppressor 
gene p53 which is a transcription factor for many proteins involved in apoptosis. 
Thus, p53 mutation may increase the activity of anti-apoptotic proteins and similarly 
decrease the activity of pro-apoptotic proteins[79]. This could result in preventing 
the release of cytochrome c from mitochondria and inhibition of caspases. It is 
postulated that cancer cells maintain a more reducing environment due to their higher 
metabolic rate [79]. This could affect the redox potential of the cell, making it more 
reducing. p53 plays a crucial role in cell fate, there are other p53-independent 
mechanisms that cancer cells use to promote tumour growth via mutation of these 
genes (so called proto-oncogenes). Proto-oncogenes are involved in cell proliferation 
such as (growth factor receptors, signal-transduction proteins, or transcription 
factors).    
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1.6 Redox regulation and other forms of cell death 
1.6.1 Necrosis 
In contrast to apoptosis, necrosis is an uncontrolled cell death due to disease, 
extrinsic or bioenergetic stimuli. Necrosis is characterised by distinct morphological 
features such as loss of cellular membrane integrity (organelles rupture, ion 
pumps/channels lose function) and consequently the cell swells and the plasma 
membrane ruptures.  Often an inflammatory response occurs in the surrounding 
tissue. These features are due to mitochondrial dysfunction (ROS production, failure 
of Ca2+ homeostasis), ATP depletion (bioenergetic catastrophe), perinuclear 
clustering of mitochondria and activation of proteases. Unlike apoptosis, during 
tissue injury necrosis can be observed in many cells in the same region and it has 
been proposed that it occurs in a more oxidising redox environment (Table 1.3). 
Necrosis is mediated by several genotoxic factors: ROS, excess of cytosolic calcium, 
proteases, and pro-inflammatory molecules. Hirsch et al. reported that excessive 
oxidation may cause disruption of enzymatic caspase activity thus shifting the cells’ 
choice from apoptosis to necrosis[80]. Another component that is also capable of 
initiation of necrosis is the nuclear enzyme PARP. PARP is stimulated by formation 
of breaks in DNA. PARP destabilizes chromatin allowing access of DNA repair 
enzymes to the damaged part of DNA. The activation of PARP that leads to necrosis 
is by depletion of NAD+, which prevents cells from using glucose as a major 
metabolic substrate [81]. Interestingly, the inhibition of PARP can promote genomic 
instability and consequently initiate tumourigenesis; on the other hand, when a cell 
lacks other components such as BRCA1, inhibition of PARP contributes towards the 
induction of necrosis (this process is known as synthetic lethality)[82]. Necrosis has 
recently been identified to be executed by molecular mechanisms and pathways 





A fairly recently reported form of cell death is ferroptosis, characterised form of cell 
death by iron-dependent accumulation of lethal lipid ROS. The term ferroptosis was 
first used in 2012 by Dixon et al. [83], where a mass molecule erastin inhibited a 
cysteine-glutamate antiporter, an essential system providing cystine for the cells in 
cell culture, and a precursor of glutathione synthesis. It has been described as a 
regulated form of necrosis, however it is distinct from this type of cell death (Table 
1.3). To date, mechanisms involved in this type of cell death remain only partly 
understood, however ROS and bioenergetic catastrophe is a characteristic of this 
form of cell death [84]. In particular, the GSH peroxidase 4 (Gpx-4), which works 
through catalysis of hydrogen peroxide to water using GSH as an essential cofactor, 
has been shown to be related to ferroptosis as it prevents detrimental phospholipid 
oxidation [84]. The depletion of GSH pool from the cell, inhibited Gpx-4 thus 
increasing lipid and cytoplasmic ROS [84].   
 It has been shown that ferroptotic proteins can be used as a biomarkers or targets to 
induce cell death in cancer. Recently, Doll et al. showed that Acsl4, which is 
involved in cellular lipid composition, contributes to cellular lipid composition, in 
particular to the death signals formation by oxidised lipids [85]. This study focused 
on triple negative breast cancer cells, which are negative for Acsl4, were highly 
resistant to ferroptotic form of cell death [85]. Thus determination of redox potential 
status may play here a crucial role in that type of cellular demise, as well as be useful 




1.6.3 Necroptosis  
Necrosis as a programmed event can be identified in multiple tissue failure 
(ischaemia), neurodegeneration and trauma [86].  Necroptosis shares the same 
morphological features as necrosis, however it is induced by external stimulation of 
death domain receptors by apoptotic ligands: TNF-α, Fas ligand (FasL) and TRAIL. 
It is initiated when apoptosis cannot be executed (e.g. during inhibition of 
caspases)[86] [87]. 
A family of receptor interacting protein (RIP) kinases has been identified to play 
crucial roles in regulating cell fate (survival or death). This family consists of seven 
members, from which RIP1 kinase activation is required to initiate the necroptosis 
pathway [87]. It has been identified that RIP1 requires uncoupled mitochondria to 
function (generation of ROS, ATP depletion) [86].  
To this date has not been shown in vivo, other than in genetically manipulated 
scenarios that suppress apoptosis. Through the evolution of cancer, tumour cells are 
known to gain resistance towards apoptotic cell death by acquiring genetic and 
epigenetic alterations. However, it has been reported that necroptosis has been 





Apoptosis Necrosis Ferroptosis 
Single cells / small 
clusters 
Population of cells Single cells/ small clusters 
Cell shrinkage Cell swelling rounding-up of the cell 
GSH-depletion Excessive ROS production,  
failure of Ca2+ homeostasis  
Bioenergetic catastrophe 
Accumulation of ROS and 
Iron 
GSH-depletion due to 
decrease in cysteine uptake 
 




Perinuclear clustering of 
mitochondria 
Reduction of size in 
mitochondria, condensed 
mitochondrial membrane, 





Pyknosis, karyolysis Lack of chromatin 
condensation, nucleus 
preserves its size 
Intact cell membrane Disrupted cell membrane Intact cell membrane 
Cytoplasm retained in 
apoptotic bodies 
Cytoplasm leakage No evidence of plasma 
membrane blebbing 
Absence of inflammation Inflammatory response in 
local tissue 
Pro-inflammatory  






Autophagy, literally self-eating, is an alternative form of pro-survival that is partially 
mediated by redox signalling [89]. Nutrient deprivation, endoplasmic reticulum 
stress, ROS and hypoxia are known to induce autophagy. Autophagy can also be 
induced as a stress response: for example, HIF1 and E2F transcription factors induce 
BNIP3 which competes with Beclin1 for Bcl-2 (Figure 1.12).  
Autophagy has multiple physiological and pathophysiological functions. When a cell 
encounters an environmental stress such as starvation or infection, autophagy takes 
place resulting in either (1) adaptive survival in which cells return to normal when 
conditions improve or (2) cell death.  Several studies have shown that oxidative 
damage associated with mitochondrial dysfunction can trigger autophagy [90].  
The blood supply to tumours is poor leading to regions that are poorly perfused with 
blood – i.e. poor nutrient supply and hypoxia, both of which are key triggers for 
autophagy. These cells undergo autophagy and in this case, it is a protective 
mechanism to allow cells to survive stressful conditions (provide cells with key 
nutrients to survive). 
 
Figure 1.12: Autophagy regulation in response to stress. Autophagy induction 
by mechanisms sensing hypoxia or oxidative stress. E2F promotes BNIP1. 
Induction of apoptosis occurs via BNIP3 disruption of the interaction between Bcl-2-
Beclin 1; which leads to activation of Beclin1. Adapted from: [91]. 
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In mammals, autophagy acts to clear cytosolic ubiquitinated substrates – this process 
is selective and is mediated through the mammalian protein p62/sequestosome 1 
(SQSTM1). Cargo is recognised through interactions with specific receptor proteins 
[92]. Autophagosomes emerge from several sites created by the addition of new 
membranes rather than budding from existing organelles. Next, multiple proteins are 
recruited to the phagophore. The assembly of the phagophore requires class III 
phosphatidylinositol 3-kinase (PtdIns3K) complex which includes Beclin 1 – this is 
regulated by Bcl-2, an anti-apoptotic protein that inhibits autophagy [91]. The small 
molecules derived from the degradation process are transported back into the cytosol 
for protein synthesis and maintenance of critical cellular functions under stressful 
conditions [93]. 
 
1.6.5 Mitotic cell death 
Mitotic catastrophe (MC) is the delayed death during or after aberrant mitosis [55, 
94]. It is not a pure death executioner pathway but an oncosuppressive mechanism 
that is initiated by perturbations in the mitotic apparatus, initiated during M phase 
and paralleled by some degree of mitotic arrest. It can ultimately trigger cell death or 
senescence.  
Mitotic catastrophe can be induced by many factors such as: directly by DNA-
damaging agents (e.g. ionizing radiation, anticancer drugs), interference with 
chromosome segregation machinery (microtubule destabilizers).  
Morphologically MC hallmarks include the characteristic formation of giant cells 
with abnormal multiple nuclei. It also displays some apoptotic characteristics such as 
loss of mitochondrial membrane potential and activation of caspases. Cells 
undergoing mitotic catastrophe are known to have increased DNA content 
(tetraploid). It has been reported, that p53 mediates expression of PUMA and BAX 
that are promoting death of tetraploid cells [95]. Biochemically, following patterns 
have been identified to execute MC: caspases, release of cytochrome c, chromosomal 
condensation, DNA degradation. 
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It has been shown that cells arrested at the G2-M transition or in mitosis might be 
mediated by CDK1 which is capable of phosphorylation of surviving and therefore 
induction of apoptotic or anti-apoptotic signals. It has also been reported that CDK1 
phosphorylation of Bcl-XL component is inhibiting the induction of cell death.  It is 
also assumed that mitotic catastrophe can be mediated by p53 [94]. 
MC induction contributes to sensitisation of cancer cells. Since the tumour cells are 
aneuploid or tetraploid, they are more prone to aberration during mitosis and 





1.7 Project Aims 
The current understanding of redox potential is that it is one of the mediators of the 
cellular behaviour and fate regulating cysteine switches of proteins.  
It is hypothesised that accumulation of harmful radicals and consequent rise in 
critical threshold of redox potential results in triggering apoptotic pathways [41]. The 
driving force for this is redox potential and it is also postulated that it is a driving 
force for the initiation of apoptotic events. The aim of this project is to investigate 
the redox potential at different stages of apoptosis and to correlate this change with 
hallmarks of apoptosis. Encompassed in these investigations is the determination of 
whether the redox potential is the cause or a consequence of the apoptotic process. 
To date, the redox regulation and oxidative stress in cell death has not been clearly 
distinguished, due to a complexity of interplay between molecules and its 
environment as well as lack of sensitive enough methods to capture subtle changes. 
The specific aims of the project were: 
(1) To establish methodology for investigation of the intracellular redox 
potential.  
(2) To carry out time course measurements of redox potential throughout 
apoptosis and correlate this with established biochemical markers in single 
cells at a population level. 





Chapter 2 Materials and methods 
2.1 Reagents  
Reagents and chemicals were purchased from Sigma-Aldrich (Poole, UK) or Thermo 
Fisher Scientific (UK) unless otherwise stated. Gibco and Invtrogen products were 
from Thermo Fisher Scientific. 
2.2 Cell culture 
Immortalised human cervical cancer, HeLa cell line, was obtained from the ATCC 
and cultured as a monolayer in Earl’s Modified Eagle Medium (EMEM) containing 1 
mg/ml D-glucose further supplemented with 10 % Foetal Bovine Serum, 1 % L-
glutamine. The cells were kept at 37 oC and 5 % CO2 in a humidified atmosphere 
containing 5 % CO2. Cells were kept below 80 % confluency. 
2.3 Apoptosis induction conditions 
2.3.1 Staurosporine 
Synchronous apoptosis was induced with 1 µM staurosporine (STS) (Invitrogen) as a 
trigger. A stock of 1 mg/ml STS in DMSO (Sigma Aldrich, St Louis, USA) was kept 
at -20 oC. Cells were washed twice with phosphate buffered saline (PBS; GS 
Chemicals) and serum-free MEM medium, supplemented with 2 mM L-glutamine, 
100 U/ml penicillin, 100 µg/ml streptomycin and 1% non-essential amino acids was 
applied. Staurosporine was added at indicated time points in a reverse time course 
manner.  
2.3.2 UV-B radiation 
Ultraviolet-B (UV-B) induced apoptosis was used as an alternative to staurosporine 
induced apoptosis. 100, 200 or 400 mJ/cm2 UV-B was used as a trigger.  
HeLa cells were seeded at a density of 20,000 per well in six-well plates or 32 mm2 
single petri dishes.  100, 200 or 400 mJ/cm2 UV-B was used as a trigger of 
apoptosis. The intensity of the UV-B exposure was determined using a UV meter 
(Scientific Laboratory Suppliers, Ltd.).   
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Final dose (µJ) / meter reading = time required (s) 
Exposed cells were incubated at 37oC for the indicated time and detached with 
versene (Gibco, UK), followed by staining, using the methods outlined below. 
2.4 Flow cytometry  
Ratios for HeLa-roGFP2 cells were obtained on the Attune Acoustic Flow Cytometer 
(Life Technologies Ltd.). Cells were excited using laser lines at 405 nm (50 
milliwatts) and 488 nm (150 milliwatts). Emission filters were 510/30 for both 
excitation wavelengths. 
2.4.1 Annexin V/Propidium Iodide staining 
Annexin V and propidium iodide staining of the cells allows for distinction between 
living cells (double negative), apoptotic (annexin V positive and propidium iodide 
negative in first instance and then double positive at later stages and death of the 
cell), necrotic (annexin V negative and propidium iodide positive). More details of 
the mechanism of work are given in section 4.1.9 of this thesis. The method used was 
developed by the Gregory Lab Voss et al. [96] 
Cells were seeded at a density of 200,000 cells per 32 mm2 single petri-dish. 
Following the appropriate treatment cells were trypsinised and spun down at 250 x g. 
Supernatant was removed and cells were washed once in 2 ml PBS and spun down 
again at 250 x g, then resuspended in 100 µl annexin V (AxV) binding buffer (140 
mM NaCl, 10 mM HEPES, 2.5 mM CaCl2) and incubated with 1 µl AnnexinV-FITC 
(Invitrogen) for 15 minutes at 4 ˚C. Next 300 µl AxV-binding buffer was added and 
AxV binding was analysed by flow cytometry and compared to unstained controls. 
10 µl (20 µg/ml) propidium iodide (Sigma Aldrich) was added 1 minute before 
analysis.  
2.4.2 JC-1 staining 
HeLa cells were seeded at a density of 350,000 cells per 60 mm2 single petri dish. 
Following staurosporine or UV treatment cells were trypsinised and centrifuged at 
400 x g at 20 oC for 5 minutes. Cells were stained with JC-1 according to the 
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protocol by Enzo Scientific where the reagent was obtained from (Enzo Scientific). 
Briefly, cells were washed in 1 ml of 1x assay solution (5 ml assay solution 
contained: 0.5 ml of 10 x component A, 0.1 ml of 50 x component B and 4.4 ml 
dH2O), centrifuged again, then resuspended in 400 µl dual detection reagent (per 
every 1 x assay solution 10 µl JC-1 was added) and incubated for 15 minutes in the 
dark. Analysis was performed by flow cytometry (Coulter Epics) and compared to 
unstained controls. 
2.4.3 Tetramethylrhodamine, Methyl Ester, Perchlorate  
HeLa cells were seeded at a density of 20,000 cells per well in six-well plates. 
Following the staurosporine or UV-B treatment cells were detached with EDTA, 
centrifuged at 150 x g at 20 oC for 5 minutes, washed with cold PBS and spun again. 
Supernatant was removed and the cell pellet was resuspended in 100 µL of AxV 
binding buffer (140 mM NaCl, 10 mM  HEPES,  2.5 mM  CaCl2)  and stained with 
20 nM tetramethylrhodamine, methyl ester, perchlorate (TMRM) (Life 
Technologies) for 30 minutes in the dark at 37˚C. Analysis was performed using 
flow cytometry (Attune Acoustic Flow Cytometer) and compared to unstained 
controls. 
2.4.4 Caspase -3 and -7 activity staining  
HeLa cells were seeded at a density of 20,000 cells per well in six-well plates.  
Following staurosporine  or  UV-B  treatment,  cells  were  detached with EDTA,  
centrifuged  at  150 x g  at  20 oC  for 5 minutes, washed with cold PBS and spun 
again. Supernatant was removed and the cell pellet was resuspended in 100 µl of 
AxV binding buffer (140 mM NaCl, 10 mM HEPES, 2.5 mM CaCl2) and stained 
with 3 µM DEVD caspase-3/7 detection reagent for 30 minutes in the dark at 37 ˚C. 
Analysis was performed using flow cytometry (Attune Acoustic Flow Cytometer) 
and compared to unstained controls.  
2.4.5 Annexin V-PerCP-Cy5.5 staining  
HeLa cells were seeded at a density of 200,000 cells per well in six-well plates.  
Following staurosporine  or  UV-B  treatment,  cells  were  detached with versene,  
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centrifuged  at  150 x g  at  20 oC  for 5 minutes, washed with cold PBS and spun 
again. Supernatant was removed and the cell pellet was resuspended in 100 µl of 
AxV binding buffer (140 mM NaCl, 10 mM HEPES, 2.5 mM  CaCl2)  and stained 
with Annexin V-PerCP-Cy5.5 (Biolegend, UK) for 30 minutes in the dark at 37˚C. 
Analysis was performed using flow cytometry (Attune Acoustic Flow Cytometer) 
and compared to unstained controls. 
2.4.6 Cell cycle 
Cell cycle phase distribution was analysed using SYTOX Red (Invitrogen, UK). 
Briefly, asynchronous cells were seeded at a density of approximately 200,000 cells 
per well in six-well plates and left overnight to allow adherence. Cells were detached 
with versene into single cell suspension and fixed with ice cold 70 % ethanol and left 
at -20 oC overnight. Cells were stained in PBS solution containing 20 µg/ml RNase 
A and incubated for 30 min at 37 oC. Prior to analysis, 1.5 µl of SYTOX Red was 
added and the samples were incubated in the dark at room temperature for 30 
minutes. The distribution of the cells in the cell cycle was measured by flow 
cytometry (Attune Acoustic Flow Cytometer). Flow cytometry analyses were 
performed using Attune Cytometric Software (Life Technologies, UK). 
2.4.7 Bongkrekic acid (BKA) mitochondrial depolarisation 
Bongkrekic acid binds to the adenine nucleotide translocase fixing its conformation 
in matrix state (m-state) preventing mitochondrial depolarisation. Further explanation 
on BKA binding and function can be found in section 4.1.17. [97] 
Cells were plated at a density of 20,000 cells per well in 24-well plates and left 
overnight to adhere. The following day, cells were washed with PBS and incubated 
with 100 µM Bongkrekic acid (BKA) for 1.5 hours. Cells were then treated with 1 
µM staurosporine in a reverse time course. Cells were detached with versene and 
stained with TMRM as described previously.  
2.4.8 DAPI staining  
Cells were seeded in 12-well plates on sterile coverslips in monolayers at a density of 
200,000 cells per well and grown for a further 24 hours. Each coverslip was washed 
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three times with PBS. The cells were permeabilised on the coverslips using 1 % 
formaldehyde for 30 minutes at a room temperature, followed by washing with PBS. 
The coverslips were mounted on to slides using DAPI-containing Vectashield hard 
set mounting medium (Vector Laboratories, Peterborough, UK) in drop-wise 
manner. Slides were analysed using an inverted fluorescent Zeiss Axiovert 25 
microscope (Carl Zeiss Ltd.) and a digital camera (Leica DFC425C). 
2.4.9 Hoescht33342 staining  
Cells were seeded in 24-well plates on sterile coverslips in monolayers at a density of 
200,000 cells per well. Cells on coverslips were washed three times with PBS. The 
cells were incubated with Hoescht33342 (Thermofisher, UK), an organic compound 
bisbenzimide, nuclear stain for 10 minutes and analysed using Cytation 3 
fluorescence plate reader and imager. Images were processed with ImageJ software. 
2.5 Surface Enhanced Raman Spectroscopy 
2.5.1 Functionalisation of nanoshells with AQ, NQ, MBA 
Surface Enhanced Raman Spectroscopy based method was developed by the 
Campbell lab. It uses redox-responsive molecules mounted onto the gold-
nanospheres that when inserted into the biological cells give a quantitative, real-time 
reading of the environment the sensor is currently at. More detailed explanations of 
the sensor structure as well as the background to the method are contained in Chapter 
5.  
Gold nanoshells (NS) (Nanospectra Biosciences, Inc.) used in this study were 
characterised by 125 nm silica core and 25 nm gold shell thickness. In-house made 
bis-(2-anthraquinone carboxamide) (AQ) [98] and  1,8-diaza-4,5-dithia-1,8-di(2-
chloro-[1,4]-naphthoquinone-3-yl)octane (NQ) [99] were used for functionalization. 
para-mercapto benzoic acid (MBA) [100] and 1mM AQ (final 1% DMSO) were 
incubated overnight with NS in the dark at room temperature. NQ nanoparticles were 
prepared in a 9:1 water:EtOH mixture. The UV-Vis spectra were taken before and 
after two (AQ-NS, MBA-NS) and three (NQ-NS) washes with deionised water. 
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2.6 Surface Enhanced Raman Spectra acquisition from 
nanosensors in cells 
2.6.1 Measurements of NQ-NS 
HeLa cells were seeded onto a glass coverslip (18 mm in diameter) in 12-well plates 
at a density of 60,000 cells per well and left to attach overnight. The following day, 
cells were washed 2 times in PBS and serum-free medium was added. After two 
hours functionalised NS were added (to a final concentration of 10 fM) and were left 
overnight for cellular uptake. The next morning cells were washed with PBS to 
remove unabsorbed NS and the medium was changed to fresh serum-free medium 
supplemented with 2.5 mM HEPES. Cells were stimulated or unstimulated with 1 
µM staurosporine for 2-6 hours incubation.  
Spectra were acquired with a Reinshaw inVia Raman microscope Raman 
spectrometer. A 785 nm diode laser along with a 50x Olympus long working 
distance objective was used. First an overall map was established. Then a detailed 
scan was performed with 1x 1mm steps in y- and x-axis. NQNS and AQNS SER 
spectra were acquired over 30 seconds with 10 % laser power (0.1). For both 
nanosensors, spectra smoothing and a baseline correction were evaluated using 
Origin 8.5.1 software.  
2.6.2 Measurements of AQ-NS and MBA-NS 
HeLa cells were seeded onto a Raman graded glass coverslip (13 and 26 mm in 
diameter) in 12-well plates at a density of 60,000 and 35,000 cells per well 
respectively and left to attach overnight. The following day, cells were washed 2 
times in PBS and serum-free medium was added. After two hours functionalised NS 
were added (to a final concentration of 10 fM) and were left overnight for cellular 
uptake. The next morning cells were washed with PBS to remove non-adsorbed NS 
and the medium was changed to fresh serum-free medium supplemented with 2.5 
mM HEPES. Cells were stimulated or unstimulated with 1 µM staurosporine for the 
indicated times. 
Spectra were acquired with a Reinshaw inVia Raman microscope Raman 
spectrometer. A 785 nm diode laser along with a 60x Olympus water immersion 
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objective was used. First an overall map was established. Then a detailed scan was 
performed with 1 mm by 5 mm steps in y- and x-axis respectively. AQ-NS and 
MBA-NS SER spectra were acquired over 10 seconds with 50 % laser power. For 
both nanosensors, spectra smoothing and a baseline correction were evaluated using 
MatLab R2015b software. 
2.7 Transmission Electron Microscopy 
Cells were grown in 35 mm2 petri dish at a density of 350,000 cells and they were 
treated with nanosensors (NQ-NS, AQ-NS, MBA-NS) using the procedures 
described in sections 2.7.3 and 2.7.4 of Materials and Methods. Preparation of TEM 
sections was perfomed by Dr Stephen Mitchell at the University of Edinburgh TEM 
facility. Briefly, the cells were washed two times with PBS and fixed for 15 minutes 
in 0.5 % glutaraldehyde in 0.2 M Pipes pH 7.2. The cells were then scraped off and 
centrifuged for 15 minutes at 10,000 x g followed by fixation for another 30 minutes 
at room temperature (20 oC). Cells were washed three times with 0.1 M sodium 
cacodylate buffer, and then ultrathin sections were cut and positioned onto a grid. 
Grids were analysed by transmission electron microscope (CM120 Biotwin, 
Phillips).  
2.8 Whole cell protein extraction 
200,000 exponentially growing cells were plated onto 6-well plates and treated with 
1 µM staurosporine. At the appropriate time-point cells were washed twice in PBS at 
room temperature. Cells were resuspended in cold reducing lysis buffer (10 mM 
HEPES (pH 7.0), 1 mM EDTA (pH 7.4), 1 % triton-x-100). Protease inhibitors were 
added (10 mM leupeptin, 1 mg/ml pepstatin, 2.3 mg/ml aprotinin, 250 mM ALLN). 
The plates were incubated on ice on a horizontal shaker for 20 minutes. Cells were 
scraped off the surface and the suspension was mixed for 30 minutes at 4 oC. The cell 
lysate was centrifuged in a Micro 200R microcentrifuge (Hettich Zentrifugen, 
Germany) at 14,000 x g at 4 oC for 10 minutes. The supernatant was collected, 
aliquoted, and stored at -20 °C overnight or until required.  
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2.9 Bradford assay 
The protein concentrations of whole cell extracts were determined using a Bradford 
assay. The Bio-Rad Protein assay reagent (Bio-Rad, Hemel Hempstead, UK) was 
used to measure the absorbance at an optical density of 595 nm using a plate reader 
(Whatman, UK). As a reference for calculation of the protein concentration, a series 
of bovine serum albumin (BSA) concentrations were used.  
2.10 Western blotting 
Separation of proteins was performed by SDS-polyacrylamide gel electrophoresis 
(SDS-PAGE). Protein samples were prepared in loading buffer containing NuPAGE 
LDS Sample Buffer (106 mM Tris HCl, 141 mM Tris Base, 2% LDS, 10% Glycerol, 
0.51 mM EDTA, 0.22 mM SERVA Blue G250, 0.175 mM Phenol Red, pH 8.5) and 
NuPAGE Sample Reducing Agent 50 mM dithiothreitol (DTT), (Novex by Life 
Technologies, UK) following denaturation at 70 °C for 5 minutes and loading on to a 
4-12 % SDS-polyacrylamide gel (NuPAGE, Life Technologies, UK). The SeeBlue 
Plus2 Prestained Standard (Novex by Life Technologies TM, UK) was used as a 
protein marker (3-198 kDa fragments). Electrophoresis was performed at 200 V for 
35 min in MES SDS Running Buffer (50 MM MES. 50 mM Tris Base, ,0.1 % SDS, 
1mM EDTA, pH 7.3) (Novex by Life Technologies, USA). The separated proteins 
were then transferred onto an Immobilon-FL polyvinylidene difluoride (PVDF) 
membrane, 0.45 μm pore size (Amersham HybondTM-P, GE Healthcare, CA, USA), 
at 30 V for 1.5 hours in NuPAGE transfer buffer (25 mM Bicine, 25 mM Bis-Tris 
(free base), 1 mM EDTA, pH 7.2). The membrane was blocked for 1 hour at room 
temperature in 5 % dried skimmed milk in PBS containing 0.1% Tween-20.  
The primary antibodies were diluted according to Table 2.1 in PBS supplemented 
with 0.1 % Tween-20 and 5 % dried skimmed milk. Membranes were incubated as 
indicated in Table 2.1 and after being washed three times in PBS and 0.1 % Tween-
20; then incubated for 1 hour with the appropriate secondary antibody diluted 
according to Table 2.1. The membranes were washed six times in PBS containing 0.1 
% Tween-20 and visualised using the chemiluminescence method. Briefly, 
AmershamTM ECL Detection Reagents were mixed in 1:1 ratio and protein bands 
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were visualised using Amersham High Performance Chemiluminescence Film (GE 





Clone Dilution Incubation time 
anti-human caspase 3 (NEB, 
Cell Signalling Technology, 
9662S) 
Rabbit (IgG) Polyclonal 1:2,000 1.5 hours 










1:5,000 1 hour 
Table 2.1: Table shows type of antibody used, dilution and time of incubation. 
2.11 Cell proliferation  
Cells were plated at a density of 20,000 cells per well in 12-well plates, grown 
further and counted every 24 hours for 5 days. For counting cells were washed once 
with PBS, then trypsinised and neutralised with complete MEM medium containing 
10 % FBS. They were then diluted in trypan blue 1:1 (v/v) and analysed on a 
haemocytometer by Olympus Microscope CKX41 (Olympus Optica Ltd., Japan). 
Each count was performed in duplicate. Each experiment was repeated three times.   
2.12 Plasmid transfection  
Cells were transfected using FuGENE transfection reagent (Promega, UK) according 
to the manufacturer’s protocol. Briefly, 6 cm2 dishes containing 300,000 adhered 
cells were prepared for plasmid transfection. Per plate, 8 µL Fugene 6 was incubated 
in MEM without FBS for 5 minutes at room temperature. Then 1 µg of relevant 
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plasmid was added to the diluted Fugene 6 complex and incubated for 15 minutes at 
room temperature. The Fugene 6-DNA complex was added to the cells in a drop-
wise manner. The plates were incubated at 37 °C for 24 hours, the media washed off 
and replaced with media containing 400 µg/ml selection antibiotic Neomycin (G418, 
Sigma Aldrich). The cells were harvested at 24 hour post-transfection unless 
otherwise stated. roGFP positive cells were separated from the negative cells via 
Fluorescence Assisted Cell Sorting (BD FACS Aria II, BeckmanCoulter). 
2.13 DNA purification 
Plasmids were purified from 7 ml of transformed bacterial culture using the Qiaprep 
Miniprep kit (Qiagen, Crawley, UK) according to the manufacturer’s protocol. 
Plasmid DNA concentrations were determined using the NanoDrop ND-1000 
Spectrophotometer (software version V3.5.2).  
2.14 Statistical analysis 
Results are presented as a mean ± standard deviation. Data from at least three 
independent biological experiments was used. Statistical analysis was performed 
using student’s paired t-test with a two-tailed distribution. Values of p<0.05 were 
considered statistically significant. 
2.15 Plasmids  
roGFP1 and roGFP2 proteins were generated from the peGFP plasmid containing the 
roGFP1 or roGFP2 gene insert that was purchased from Remington’s Lab at the 
University of Oregon. [101, 102]  
Plasmids pENGFP containing either roGFP1 or roGFP2 were purified from 7 ml of 
transformed bacterial culture using the Qiaprep Miniprep kit (Qiagen, Crawley, UK) 
according to the manufacturer’s protocol. Plasmid DNA concentrations were 
determined using the NanoDrop ND-1000 Spectrophotometer (software version 
V3.5.2) at a wavelength of 230 nm. 
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2.16 Plasmid and Protein purification  
2.16.1 Transformation 
Plasmids containing eGFP sequence were centrifuged for 1 minute at 500 x g  and 
inserted into BL21(DE3) competent cells and  C2987 cells followed by incubation on 
ice for 25 minutes, heat shock (42 °C for 40 seconds), and incubation on ice for 2 
minutes. 100 µL SOC media was added and samples were further incubated on ice 
for 1 hour. Cells were streaked onto an agar plate with 100µg/mL Ampicillin (Sigma 
Aldrich, UK) antibiotic and incubated at 37 °C overnight. 
2.16.2 Induction 
A single colony from each agar plate was selected and added to separate 250 ml 
lysogeny broth (LB) containing 100µg/mL ampicillin and incubated overnight at 
37oC.  
The starter cultures were then diluted to OD600 ≈0.1 in LB broth (500 ml) with 
AMP100 (100 µg/ml). Colonies were kept at 30 oC until its OD600 reached 0.6 ~ 0.8. 
Samples were induced with 500 µl of IPTG and further incubated for 3 hours 
followed by centrifugation at 433,664 x g for 10 minutes. Supernatant was then 
discarded and the pellet was resuspended in PBS and stored at -20 °C. 
2.16.3 Recombinant protein purification 
Recombinat roGFP2 and eGFP from E.coli purification procedure was performed by 
Menglu (Lily) Wang at the EaStCHEM School of Chemistry, University of 
Edinburgh. 
2.16.4 Cell lysis 
Cells were resuspended in 25 ml binding buffer followed by sonication for 15 
minutes (30 seconds on/off). After sonication the buffer solution was centrifuged at 
108,416 x g for 30 minutes at 4oC.  50 µl of the supernatant was retained and filtered.  
2.16.5 Ni resin 
3 ml of Ni resin was added to the filtered supernatant and gently spun for 1 hour at 4 
oC. The mixture was injected into the filter cartridge. The mixture was allowed to 
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flow through, leaving the resin in the filter cartridge. The washing buffer was then 
added through the resin followed by the elution buffer.  
2.16.6 Dialysis 
Samples were dialysed at 4 °C for 2 hours using MWCO 8K dialysis tubing. 
2.16.7 Gel filtration 
The sample volume was decreased to 6 ml by centrifugation. The protein sample (6 
ml) was filtered and loaded into a Superdex200 filtration column (GE Healthcare 
Life Sciences) and pre-equilibrated. (flow rate: 0.7 ml/min, pressure alarm: 0.3 mPa). 
The eluted samples were collected in fractions which were tracked using 280 nm 
UV. Protein was stored in 1 ml aliquots at -80 oC in glycerol until further use.  
2.17 roGFP2 protein amine conjugation to N-
hydroxycuccinimide (NHS) magnetic beads 
2.17.1 Dialysis  
roGFP2 protein was thawed on ice following an overnight dialysis in Sodium 
Phosphate buffer (pH 7.2) at 4 oC using a 0.5 ml Slide-A-Lyser Dialysis Cassette 
MWCO 7K (Thermo Fisher Scientific, UK).  
2.17.2 Coupling and blocking 
Protein and magnetic beads were equilibrated to room temperature. 10 mg/ml beads 
were placed into the microcentrifuge tube and placed on a magnetic stand; beads 
were collected and the supernatant discarded. Beads were washed with ice-cold 1 
mM hydrochloric acid, the pellet was collected and immediately afterwards, protein 
was added in a 1:1 (v/v) ratio and the solution was vortexed for 30 seconds and 
incubated overnight on a vertical rotator at 4 oC. The following day, the pellet was 
collected on the magnetic stand and washed with 0.1 M glycine (pH 2.0) and 
vortexed for 15 seconds. The tube was placed into the magnetic stand and beads were 
collected. This was repeated twice more, following addition of ultrapure water and 
vortexing for 15 seconds. Beads were collected on the magnetic stand and 
resuspended in 3 M ethanolamine (pH 9.0), vortexed for 30 seconds and incubated 
on a rotator for 2 hours. Next, beads with protein were washed once with purified 
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water, mixed well, collected on a magnetic stand and washed in sodium phosphate 
buffer (pH 7.2) three times. For a sodium phosphate buffer pH 7.2 use 280mL of 1 M 
NaH2PO4 with 720ml of 1 M Na2HPO4.  Beads were resuspended in sodium 
phosphate buffer (pH 7.2) to a final concentration of 10 mg/ml.  
2.17.3 Flow cytometry analysis  
All solutions were prepared fresh on the day, degassed with Nitrogen gas and 
experiments were performed under nitrogen. Titration of proteins on beads was 
performed in sodium phosphate buffer (pH 7.2) including either of: DL-
dithiothreitol/trans-4,5-dihydroxy-1,2-dithiane, DL-6,8-thioctic acid/DL-α-lipoic 
acid or glutathione/glutathione disulphide at concentrations indicated in the FIGURE 
legends.  Samples were incubated for 2.5 hours at 25 oC. Data was collected on the 
Attune acoustic flow cytometer using the high sensitivity setting. Data was analysed 




Chapter 3  
Establishing a methodology for the investigation of 
intracellular redox potential in cells 
 
3.1 Introduction 
The first aim of this project was to establish a methodology to measure redox 
potential in cells undergoing apoptosis in single cells at a synchronised population 
level so that proposed studies at the individual cell level could be rationalised. 
Population studies are important since they enable one to determine the percentage of 
cells moving towards more reductive or oxidative redox potential values, and hence a 
systemic view of the process can be formed whereas single cell analytical approaches 
provide a mechanistic view of the process.  
In order to best determine the state of the intracellular redox potential in real time 
one has to use the following three prerequisites in the method selection process. 
Firstly, the method has to retain high sensitivity in order to detect even minor redox 
potential changes, as intracellular proteins vary in susceptibility to oxidation and will 
demonstrate a drastic change in oxidation status over a very narrow potential range 
[8]. In some cases, a change of the redox potential by 30 mV is sufficient to drive 
protein activation. Secondly, the method of choice should be as close as possible to 
non-invasive, allowing unbiased detection of downstream events. For example in the 
glutathione-focused HPLC method, glutathione has been shown to rapidly oxidise 
upon cell lysis and extraction for HPLC analysis. Thirdly, redox potential 
measurement should be reversible, to allow for real-time analysis of, often transient, 
changes in redox events.  
A comprehensive list of methods, commonly used to measure redox potential in cells 
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3.1.1 Reduction-oxidation responsive Green Fluorescence 
Proteins  
To study redox potential progression throughout apoptosis at a population level, this 
study used roGFP2 and roGFP1 since these proteins have been validated as a tool to 
measure redox potential non-invasively.  
The GFP applied in various studies commonly refers to the Aequorea GFP, which was first 
extracted from jellyfish Aequorea Victoria. Among all the natural GFP, only the gene of 
GFP in Aequorea Victoria was cloned and expressed. Further studies on the structure of GFP 
have lead to modifications of the structure and sequence of amino acids, that lead to creation 
of various clones of roGFP. A comprehensive review by Swarzlander et al. summarises most 
up to date grand prix of GFP selection [10]. Redox responsive Green Fluorescent Protein 
consists of 238 amino acids and its molecular weight is 26 kDa. It is composed of 
antiparallel β-strands. Both ends of the roGFP are capped by short helixes antipodes, 
which restrict accessibility of solvents to the inferior structure of the protein [9, 10].  
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Figure 3.1A. Top and side view of reduced roGFP2 visualised in PyMOL PDB ID 
1JC1 (oxidised form) 1JC0 (reduced form). B. Structure and formation of the 
chromophore of GFP2 created in ChemDraw. Red indicates Cys147 and Cys204 side 
chains. 
 
The green light emitting 4-(hydroxybenzylidene) imidazolidin-5-one chromophore is 
formed by three sequential residues on the interior coaxial helix: Ser65, Tyr66, 
Gly67 (Figure 3.1). The mutation Ser65Tyr increases the fluorescence and 
photostability of wild-type GFP (wt GFP). Moreover, this contributes towards the 
shift of the major excitation peak of GFP to 488nm, making it more compatible with 
available techniques. 
Neither the naked chromophore nor unfolded GFP protein are fluorescent. However, 
the protein is extremely resistant to protease activity and this property guarantees its 
stability under harsh conditions. Two mutations, Ser147Cys and Gln204Cys make 










In publication investigating mitochondrial redox potential with roGFP indicators 
Hanson et al. described roGFP nanosensor creation in an explicit way worth citing:  
‘Redox-sensitive GFP indicators were successfully created by introduction of 
disulfides close to a conspicuous bulge in the otherwise regular GFP β-barrel. The 
bulge is centered on His148, the side chain of which partially fills the bulge and 
interacts with the chromophore phenol(ate) oxygen’. [102] 
The redox midpoint potential for roGFP1 is -291 mV and for roGFP2 it is -280 mV. 
In addition, both provide a ratiometric fluorescence readout by comparing the 
excitation bands of the protonated chromophore (397nm) to the oxidised anionic 
chromophore (475 nm for roGPF1 and 490 nm for roGFP2). However, roGFP1 can 
provide false positive results, since prolonged excitation of the chromophore may 
lead to artificial deprotonation through isomer formation. Therefore, analysis of 
oxidising conditions would be recorded as reducing, and vice versa. 
A number of reporter proteins were generated by using different variants of GFP: 
wild type (wt) or enhanced GFP (eGFP). A panel of green fluorescent proteins has 
been developed by the Remington and Tsien labs to improve the temporal resolution 
of the roGFP response to redox change. The protein has also been targeted to various 
cellular compartments such as plasma membrane and nucleus [101], endoplasmic 
reticulum [108, 109], and mitochondria [102] to report on the potential in these cell 
structures under different conditions.  
Structural and analytical properties of two roGFP variants, used in this study of 




Feature roGFP1 roGFP2 








Excitation wavelengths 400nm, 475nm 
Main peak 405nm 
400nm, 490nm 
Main peak 488nm 
Emission wavelength 510nm 510nm 
Relative brightness  Low  High  




Disulfide bond C147-C204 C147-C204 
Midpoint potential -291 mV  -280mV  
Useful reporting range at 
pH 7.2 
-328mV to -272mV -312mV to -256mV 
pH dependence Less pH dependent  Loss of fluorescence  
in non-physiological range 
(above pH 8) 
due to S65T mutation 
 Table 3.2 Summarises general similarities and differences between genetically 
encoded sensors roGFP1 and roGFP2 [107, 110, 111] 
 
The roGFP method mainly tracks changes in glutathione concentration since this is 
dependent on the Grx-1 enzyme activity. Investigation of the redox potential change 
using the ratio of reduced to oxidised roGFP protein is convenient as it can be 
measured by several different methods: confocal and fluorescence microscopy, 
fluorescence plate reader and flow cytometry, so long as the instruments are 
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Figure 3.2: A. Reduced roGFP2 B. oxidised roGFP2 visualised by PyMOL 
software PDB ID 1JC1 (oxidised form) 1JC0 (reduced form) with indicated 
reduced (C.) and oxidised (D.) states of these cysteine residues as published by 
[102]Hanson et al. E. represents the fluorescence excitation spectra of recombinant 
roGFP2 and eGFP spectra in reducing and oxidising environments. The spectra were 




Work in Chapter 3 aimed to establish grounding high – throughput methodology to 
measure the redox potential in single cells at a population level. First, stably 
transfected roGFP1 and roGFP2 HeLa cell lines were developed and the apoptotic 
capability of cells was monitored. In this chapter flow cytometry was used to validate 
roGFP1 and roGFP2 expression in HeLa cells and to monitor the changes in redox 






3.3.1 Expression of roGFP in the mammalian HeLa cells 
To establish a system to monitor redox changes in real-time, HeLa cells were chosen 
as an initial cell line with roGFP constructs as this cell line is the most studied cell 
line in the literature [112]. First, cells were transfected with the roGFP1 and roGFP2 
plasmid constructs obtained from Remington Lab (see Materials and Methods 
section 2.16). HeLa cells were transfected with circular plasmid DNA pEGFP.N1, 
containing roGFP1 or roGFP2 within the plasmid construct. Yield of transient 
transfection was 24.3% and 36% after 72 hours for roGFP1 and roGFP2, respectively 
(Figure 3.3).  
 
Figure 3.3 Transient transfection of HeLa cells with mammalian expression 
plasmids containing roGFP1 and roGFP2 – 24, 48, 72 hours post-transfection. 
Cells were analysed using the fluorescence microscope (bright field and green 
fluorescence). Pictures of the same field were taken. The percentage of positive 
transfectants was calculated. Bars represent the average of three fields per condition. 
In order to enhance and unify the population of roGFP positive cells, fluorescence-
activated cell sorting (FACS) was used and cells were collected on the basis of the 
inherent GFP signal. Following the FACS cells were immediately seeded in 96-well 
plates at a density of one cell per well to allow growth of single cell colonies in order 
to remove any genomic variability in the population of cells. A population of cells 






























Figure 3.3 continued Selection of roGFP1 and roGFP2 positive cells. 
Fluorescence Activated Cell Sort (FACS) was performed on the population of 
cells to isolate green fluorescence positive cells. The graphs show before and after 
FACS. GFP-positive populations were successfully selected at 488 nm for roGFP2 
positive cells and 405 nm for roGFP1 positive cells, as denoted by fluorescence-




Figure 3.4 Selection of roGFP1 and roGFP2 positive cells. Fluorescence 
Activated Cell Sort (FACS) was performed on the population of cells to isolate 
green fluorescence positive cells. The graphs show before and after FACS. GFP-
positive populations were successfully selected at 488 nm for roGFP2 positive cells 
and 405 nm for roGFP1 positive cells, as denoted by fluorescence-responsive 





















3.3.2 Examination of transfected HeLa cells 
In consideration of the fact that the HeLa cells had been exposed to new genetic 
material, it was crucial to see whether their cell cycle profile, ability to proliferate, 
and ability to undergo apoptotic cell death had changed.  
3.3.3 Proliferation rate 
To obtain an accurate estimate of the cell proliferation rate, exponentially growing 
cells were seeded in 12-well plates at 20,000 cells per well and three wells per cell 
line were counted every 24 hours for 5 consecutive days until the cells reached full 
confluency (Figure 3.5).  
Cells were trypsinised, stained with trypan blue, and counted using a 
haemocytometer. Trypan blue dye, which is membrane impermeant and generally 
excluded from viable cells, was used to assess the viability of the population; 




Figure 3.5 Comparison of the proliferation rate of non-transfected and 
transfected cells; HeLa cells (blue line), HeLa-roGFP1 (red line), HeLa-roGFP2 
(green line). Cells were seeded and counted every 24 hours until confluent. Data 
shows the averages of three repeats per condition from two independent experiments. 
No significant differences in growth rates were observed between HeLa and HeLa-
roGFP2 cells. However, the HeLa-roGFP1 cell line showed a slower proliferation 




























3.3.4 Cell cycle 
To confirm and further investigate the cell proliferation rates, the cell cycle of the 
cells was analysed by monitoring their DNA content.  
In a given population of cells there are three major phases of the cell cycle. These 
include:  
 G0/G1 phase where a single cell has one set of chromosomes; 2N 
 S phase where a single cell has a variable amount of DNA due to DNA 
synthesis; >2N<4N 
 G2/M phase where a cell has two full sets of chromosomes prior to cell 
division; 4N.  
Flow cytometry is commonly used for analysis of DNA content. The cell cycle 
profile was acquired using SYTOX Red stain, which binds to nucleic acids including 
RNA and double stranded DNA with little or no sequence preference and emits a 
signal proportional to the mass of DNA it is bound to. To determine cell cycle phase, 
exponentially growing cells were taken from the culture and fixed with 70% ice-cold 
ethanol. Cells were then treated with RNase A to eliminate nucleic acid material 








Figure 3.6 Cell cycle profiles of HeLa cell lines stably transfected with roGFP1 
and roGFP2. A shows representative cell cycle profiles for HeLa, HeLa-roGFP1 
and HeLa-roGFP2. B. cells shows percent of cells in indicated cell cycle phase. 
Flow cytometric analysis of the cell cycle summarised in Figure 3.6 revealed that the 
HeLa cells had 4.8 % in SubG1 and 61.9 % of cells in G1. HeLa-roGFP1 cells were 
12.6 % in SubG1 (apoptotic) phase and only 38.8 % in G1; 27.9 % of cells were in S 
phase and 20.6 % were in G2/M phase. HeLa-roGFP2 cells had 7.44 % cells in 
SubG1 and 56.73 % in G1 phase, 25.3 % in S phase and 10.5 % in G2 phase. G2 
HeLa HeLa-roGFP1 HeLa-roGFP2
Sub-G1 (%) 4.82 12.64 7.44
G2 (%) 8.69 20.61 10.52
S (%) 24.63 27.99 25.31























arrest of the HeLa-roGFP1 cell line suggests that these cells are genetically 
compromised and attempting DNA repair. Moreover, the cell growth studies shown 
earlier suggest that the HeLa-roGFP1 cells grew slower and indicated that cells were 
more prone to cell death.  
3.3.5 Apoptosis – nuclear fragmentation 
The analysis of the redox potential of apoptotic cells is the focus of this study 
therefore the rate of progression through the process of programmed cell death in 
transfected and non-transfected cells was investigated. 
Chromatin condensation and DNA fragmentation are hallmarks of the later stages of 
apoptosis [37, 113]. This can be visualised by 4,6-diamidino-2-pherylinodole (DAPI) 
dye, which binds to sequences rich with adenine and thymine. These are usually 
located in the regions of the minor groove of DNA. DAPI is semi- cell permeable 
and it requires membrane permeabilisation prior to staining.  
The intensity of DAPI labelling and the morphology of the chromatin is a major 
indicator of apoptosis. Pale uniform DAPI staining of an oval-shaped nucleus 
indicates a viable cell, whereas, bright DAPI staining of irregularly shaped chromatin 
identifies an apoptotic cell. The presence of staining in the cytoplasm suggests a lack 
of nuclear condensation indicating necrosis. Figure 3.7 summarises the quantitative 
data obtained from DAPI staining of cells treated with 1µM staurosporine, an 






Figure 3.7 Percent of cells displaying nuclear fragmentation, indicating 
progression through apoptosis, induced by 1uM staurosporine in HeLa, HeLa-
roGFP1 and HeLa-roGFP2 cells and measured by DAPI staining. Data 
represents three independent experiments where more than 300 cells were counted 
per condition. Error bars indicate SEM. 
Stimulation with 1µM staurosporine and analysis of nuclear fragmentation showed 
no significant differences in apoptotic progression of non-transfected HeLa and 
HeLa-roGFP2 cells. However, these results confirmed that HeLa-roGFP1 cells 


































3.3.6 Titration of roGFP2  
In order to establish whether the redox potential, measured by the ratiometric 
property of roGFP2, can be quantified by the flow cytometry method, a standard 
potential curve was determined. This was done by titration of purified roGFP2 
protein in various redox buffers at different potentials (Figure 3.8). Purified roGFP2 
protein was expressed in E.coli and purified by Menglu (Lily) Wang, University of 
Edinburgh.  
Since the flow cytometry apparatus used in this project is able to reliably detect 
objects equal to or greater than 1µm in diameter, the roGFP2 purified protein was 
conjugated to beads with a mean diameter of 2.8 µm. This bead size provides 
sufficient area for protein attachment, but at the same time, they provide a smaller 
magnetic field, which can negatively influence separation of beads in liquid phase.  
The conjugation beads employed in this study were supramagnetic with N-
hydroxysuccinimide (NHS) functional groups. Availability of the NHS functional 
group allows for covalent immobilisation of roGFP2 protein on the beads by forming 
stable amide linkages via reaction with primary amines. The coupling reaction was 
performed in degassed sodium phosphate buffer at pH 7.2. The full scheme of 
















Figure 3.8 A. Conjugation of NHS-activated magnetic beads to roGFP2. 10µg of 
roGFP2 protein was incubated with 1mg of magnetic beads to ensure uniform 
conjugation. Protein and beads were incubated for 2.5 hours under the nitrogen 
conditions, following the analysis via flow cytometry B. Flow cytometry analysis of 
the complex formed the reduced roGFP2 was collected at excitation 488 nm (Blue 
Laser Line and emission at 503/30 nm BL1-A) and oxidised version was measured 





The hypothetical profiles of the reduced and oxidised forms of roGFP2 extracted in 
pyMOL showed no potential interference between the beads and cysteines 147 and 
204, change in hydrogen bond conformation of which defines change in the redox 
potential status. 10µg of roGFP2 protein was incubated with 1mg of magnetic beads 
to ensure uniform conjugation.  
To determine the standard curve of roGFP2, protein-conjugated beads were 
incubated in sodium phosphate buffer pH 7.2 solutions containing three soluble 
redox couples at varying ratios to obtain a specific redox potential of a solution. A 
full flow chart of the experiment is shown below:  
 
 
The redox potential of a solution can be calculated if all the variables of the Nernst 
equation are known (as shown in Chapter 1). Equilibration of the roGFP2 protein in 
such solution will cause free cysteine residues to come to a thermodynamic 
equilibrium with the solutions’ redox potential and so the redox potential of the 
roGFP2 could be determined. A series of solutions of different potentials allows for 
the more accurate calculation of the Eθ of a protein of interest. 
Table 3.3 shows redox pairs and midpoint potential of the biological redox pair in 




 Eθ [mV] at 
pH 7.0 
Reference  
DL-dithiothreitol/trans-4,5-dihydroxy-1,2-dithiane (DTT),  
 
-330 [114] 
DL-6,8-thioctic acid/DL-α-lipoic acid (LA) -288 [115] 
glutathione/glutathione disulfide (2GSH/GSSG) -240 [8, 116] 
Table 3.3 shows biological redox couples with their standard midpoint potential 
Eθ values [mV]. 
Varying ratios of the redox couples represented a continuum between fully-reduced 
(no thiol bonds present) and fully-oxidised (ubiquitous thiol bonding) variants of the 
redox couple. Each redox couple was incubated for 2.5 hours at 25oC under nitrogen 
conditions, eliminating the possibility of sample contamination with oxygen.  
During the flow cytometry analysis of the conjugated beads, roGFP2 in oxidised 
conformation was defined by intensity of the fluorescent signal after excitation at 
405nm (50mW), whereas the signal from the reporter protein with reduced roGFP2 
was collected after excitation at 488 nm (150 mW). Emission filters were 510/30 nm 
for both excitation wavelengths. The raw data ratio was plotted as a ratio of oxidised 
(on y axis) and reduced (on x axis) as seen in Figure 3.8 and the raw data was 
extracted to excel sheet to further analyse and derive a standard curve for roGFP2 by 






Figure 3.9 Redox potential standard curve for roGFP2 by flow cytometry Dot 
plot graph depicting oxidised (405 laser line, emission at 510nm) to reduced (488 
laser line emission at 510nm) ratio of roGFP2 protein conjugated to N-
hydroxycuccinimide (NHS) magnetic beads and incubated with DTT, LA or GSH 
redox couples. Individual couples were mixed at different ratios and incubated with 
protein for 2.5 hours. The ratio between detected signals from the interaction with 
reduced and oxidised couples formed a single data point on the plot at a given redox 
potential . Error bars showing standard deviation of three independent experiments. 
By mixing contrary variants of the redox couples, and thereby producing 
environments with varying redox potential, a controlled environment for recording 
the response values of roGFP2 was provided. This approach allowed the generation 
of a standard curve of response for a very broad redox potential range, between -181 
mV and -398 mV (Figure 3.9). 
Recurring trends for all 3 redox couples were observed, where an increase in the 
reducing agent concentration was detected as an increase in signal from reduced 
roGFP2 (at 405 nm) over oxidised (at 488 nm) and is reflected in the gradual 
increase in the ratio values.  
y = 0.0107x + 4.8521
y = 0.0029x + 3.4799








































During analysis of the data point trends, a linear pattern was clearly observed (Figure 
3.9) in all redox couples. By performing linear trend-line fitting, coordinates of two 
points were obtained, allowing the calculation of a gradient value for each data set. 
Saying that a change in the potential from DTT results in a sharp change in the 
fluorescence ratio, thus the roGFP2 is good at measuring this. DTT demonstrated the 
steepest increase of the data point trend, with the positive gradient of 0.0107. For LA 
and GSH the same is true, however, the fluorescence ratio changes less. roGFP2 
incubated with LA and GSH also demonstrate an increase close to linear, but 
demonstrate a different trajectory. However, at a closer look, roGFP2 in LA and 
GSH also demonstrate a positive gradient of 0.0029 and 0.0009, respectively. 
 
 
Figure 3.10 zoom in from Figure 3.9. Redox potential standard curve for 
roGFP2 conjugated to NHS-activated magnetic beads and incubated in lipoic 
acid. Followed by measurement of the fraction of reduced to oxidised substrate by 
flow cytometry. Error bars showing standard deviation of three independent 
experiments. 
3.3.7 Validation of roGFP-expressing cell lines for measuring 
dynamic changes in the redox potential 
Titration of recombinant, purified roGFP2 protein in various redox buffers allowed 
the midpoint potential of roGFP2 to be determined, which was then applied to the 
calculations of the redox potential measured in cells. Flow cytometric analysis of the 
redox potential changes during staurosporine-induced apoptosis of HeLa cells 


































during cell death (Figure 3.11). Due to large variations in the standard deviation 
values, it was difficult to determine statistical significance of this data set. However, 
an increasing trend, based on averaged values, was observed. After 6 hours of 
exposure to 1µM staurosporine, both roGFP1 and roGFP2 HeLa cell lines 
demonstrated a marked increase in the proportion of oxidised cells in the samples, 
increasing from 31% and 27.4% to 60.6% and 50%, respectively. This observation 
suggests that both of the roGFP variants are sensitive to apoptosis-driven oxidation 
and hence they are reflecting the expected cell death dynamics. Therefore, roGFPs 
represent a suitable method for measuring redox potential changes in the population 
of HeLa cells by flow cytometry.  
Changes in the oxidised species of apoptotic HeLa cells are represented in Figure 
3.12, showing that roGFP1 has a stronger response to the redox potential changes 
characteristic of early onset of apoptosis. After 2 hour of exposure to 1µM 
staurosporine roGFP1 HeLa cells demonstrated a rapid increase in oxidation-linked 
apoptosis, when compared to the performance of roGFP2 HeLa cells. Such 
discrepancy can be explained by two theories:  the roGFP1 construct may have a 
toxic effect on the cells carrying the roGFP1 construct, or it is more responsive to the 
redox change than cells expressing roGFP2. Furthermore, analysis of the redox 
potential in the untreated sample showed that cells carrying roGFP1 are more 
oxidised (oxidation in more than 27.4% of cells) even at the resting potential (Figure 
3.11). However, those cells showed faster oxidation throughout the apoptosis process 
and this would be consistent with their measurement range as indicated by the 







Figure 3.11: Detection of the oxidation status of HeLa cells by roGFP1 and 
roGFP2 fluorescent proteins in control samples and in cells with staurosporine –
induced apoptosis. HeLa cells with roGFP constructs were exposed to 1μM 
staurosporine for up to 6 hours. Error bars show the standard error of the mean of 
three independent experiments. 
3.3.8 Detection of the oxidation status in transfected HeLa 
cells (percent oxidised)  
Investigation of the percentage of oxidised species by flow cytometry of HeLa-
roGFP1 and HeLa-roGFP2 cells revealed the percent of oxidised species was 45% in 
HeLa-roGFP1 after 0.5 hour post-staurosporine treatment as opposed to HeLa-
roGFP2 cells which were 15% oxidised at this time point Figure 3.12. This suggests 
that the HeLa-roGFP1 cells were more prone to cell damage than the HeLa-roGFP2 
cells. However, this result also suggests that the oxidation of the species is higher in 
genetically modified cells that have a higher proportion of cells in SubG1 phase. A 
positive growth-over-time trend in cell oxidation was observed for both roGFP 






































Figure 3.12 Flow  cytometric  analysis  of  the proportion of oxidised species 
during staurosporine-induced  apoptosis  in clones  of  HeLa  cells  carrying  
redox-responsive  green  fluorescent proteins. This figure shows various clones of 
roGFP1 and roGFP2 populations of cells, each derived from single cell colonies.   
 
Due to the difference in the characteristics of the cell cycle and induced apoptosis in 
cells expressing roGFP1, the decision was made that this cell line would not be used 
any further in this study as it was not appropriate for use in the studies of redox 
potential.   
  
3.3.9 Development of alternative cell lines for roGFP vector 
expression 
Expression of the pEGFP plasmid, containing roGFP1 or roGFP2, by viral 
transduction or using a lipid-based method was used to transfect human (BL2) and 
mouse (lambda-myc) Burkitt’s lymphoma cell lines. In contrast to HeLa cells, both 
of these cell lines grow in an anchorage-independent manner. Both the viral and 
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lipid-based transfection approaches resulted in a successful inoculation but 
insufficient plasmid integration since expression of the constructs was poor in both 
cell types tested.  
Although different techniques and improvements were made by optimising the 
protocols, expression of the protein was not successful. Less than 5% transfection 
efficiency in all cases was observed and out of those cells none survived for more 
than 24 hours. In addition, the fluorescence of these proteins remained too dim to be 
useful in further investigation. Both cell lines exhibited high autofluorescence upon 




3.4 Discussion and Conclusions  
The first aim of this thesis was achieved by performing ground work to investigate 
the redox potential of cells via flow cytometry at a population level.  
Work described in this chapter shows that flow cytometry is a valid method to use to 
investigate the redox potential in individual cells at cells’ population level: 
 It has been shown here that the roGFP2 ratio can be detected by flow 
cytometry and successfully used as a method to investigate the redox 
potential in a cell population 
 roGFP1-transfected cells showed increased susceptibility to apoptosis when 
compared to non-transfected and roGFP2 transfected HeLa cells. 
Numerous studies report the importance of GSH as a main determinant of cell fate 
[17][16]. The depletion of GSH has been reported to be a major cause of cells to 
commit to programmed cell death [117-119]. The majority of glutathione resides are 
in the cytosol; however, the exchange of reduced glutathione between cytoplasm and 
the intracellular organelles is crucial for maintenance of the cells’ homeostasis. 
However, roGFP2 only reflects the status of the redox potential of glutathione and 
glutathione disulfide redox couple. Furthermore, this depends on the activity of 
glutathione reductase 1 enzyme (Grx-1) and its enzymatic capability. 
The difference in the cell cycle distribution of HeLa-roGFP1 cells compared to HeLa 
cells suggests that the HeLa-roGFP1 cells were genetically altered, but it also 
suggests that the cells were attempting self-repair (Figure 3.6). Normally cells rely 
on three major checkpoints as they progress through the cell cycle. At the transition 
between G1 and S phase cells are examined for normal growth patterns: potential 
space limitations and contact inhibitions, growth factor release and DNA damage. 
Following DNA synthesis during S phase, the G2 checkpoint gives the cell a chance 
to identify DNA damage or mismatches that may have been introduced during 
replication. If such a fault is found, the cell arrests its progression through the cell 
cycle at the G2 checkpoint until these errors have been corrected. In the case of 
HeLa-roGFP1 cells, transition past the G2 phase into M-phase does occur at a much 
slower rate, as chromosomal alterations are beyond repair. There is an increase in 
apoptotic cells, suggesting that many may die. This is clearly reflected in the cell 
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cycle analysis (Figure 3.6) when roGFP1-transfected cells are compared to control 
HeLa cells. 
However, cells could have been taken at different growth phases from the culture; 
therefore it was important to check whether the cell’s apoptotic ability was affected. 
The cells transfected with roGFP1 did show a faster apoptosis rate, suggesting that 
the cells were more sensitive to stimuli, becoming functionally too distant from the 
control HeLa cell line and might not be suitable for the analysis of the redox 
potential in HeLa cells.  
Furthermore, when roGFP1-transfected cells were compared to both non-transfected 
HeLa and HeLa-roGFP2 cell lines an increased susceptibility to apoptosis is 
observed, leading us to hypothesise that the roGFP1 construct may have a toxic 
effect on cells carrying the construct. 
Analysis of the redox potential showed that cells carrying roGFP1 are more oxidised 
even at the resting potential (Figure 3.3 and Figure 3.5 (middle column)). However, 
cells with roGFP1 showed faster oxidation during apoptosis, and this is consistent 
with their measurement range, as indicated by the midpoint potential. This 
observation was, however, not observed or reported previously. 
At the same time, results from the analysis of the redox potential showed that 
roGFP1 cells did indeed go faster into the more oxidative status as opposed to the 
roGFP2 cells. This may be explained in two ways:  
1) The rise in redox potential preceded the apoptosis in those cells and 
was an indicator of more rapid induction and processing of apoptosis 
in those cells, showing that the cells were more susceptible to 
staurosporine-induced apoptosis.  
2) Cells were fragile at the beginning, and more fragile cells tend to shift 
towards cell death to save the population from genetic mutation.  
This might have been followed or preceded by a rise in oxidised roGFP1 form in the 
cell. Further investigations would be desirable, however because the cells were 
genetically compromised the decision was made not to take this cell line further and 
to focus on roGFP2-transfected cells exclusively. 
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Data from purified protein showed that positive gradients, observed in all 3 redox 
couples, allowed validation of the sensitivity and response range for the roGFP2 
protein. Comparison of the gradients shows that the rate of change for the DTT 
couple was 3.7 and 11.8 times higher than in LA and GSH, respectively. 
Furthermore, the rate of change of LA was 3.2 times higher than in GSH. In 
comparison to DTT and LA, GSH has the smallest gradient with minimal changes in 
the ratio between GSH (reduced) and GSSG (oxidised) variants of the couple. On the 
basis of this observation it can be concluded that the difference between titration 
occurs because of various half-cell potentials of the redox couples.  
The reason that the purified protein was not or barely affected by different redox 
potentials in a GSH/GSSG couple might be caused by the absence of direct 
interference between roGFP2 and GSH. Such observation might be explained by the 
reactivity between roGFP2 and Grx-1, an enzyme which is responsible for the 
reduction and oxidation status of the glutathione itself and is directly linked to 
reducing or oxidising the roGFP2 protein in the cell. The roGFP2 protein does react 
to the reduction by Grx1 (glutaredoxin-1) and is equilibrated to the same redox state 
as GSH/GSSG by this enzyme. roGFP2 has a similar halfway potential to the 
glutathione therefore it is not affected as much as with the DTT or LA [9, 10].  
When the ratio of excitation 405/488 at emission 530 nm was plotted against the 
potential, the mid-point potential correlated with the potential previously reported by 
Meyer and Dick at the value of -280 mV. 
Even though the glutathione redox couple is the major buffering system in the cell, 
there are other thiol/disulfide redox couples. These include thioredoxin 1 and 2, 
NADP+/NADPH, NAD+/NADH. These couples are not in mutual equilibrium and 
are distributed differently between the cellular organelles, as discussed in Chapter 1. 
It is also important to note that GSH is only synthesised in the cytoplasm. Therefore, 
in the example of mitochondria, the mitochondrial GSH pool is dependent on GSH 
transport from the cytoplasm. It is crucial to acknowledge limitation of the 
GSH/GSSG system in tracking the redox potential, in order to gain a clear 
mechanistic and quantitative understanding of the overall redox potential state of the 
cell.  Analysis of the data, presented in this chapter, led to an interesting and 
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important question: are the changes in the redox potential preceding the apoptosis 
process and driving the cells to the point of no return? And when are cells fully 




Chapter 4  
Redox potential in cell populations undergoing 
staurosporine-induced apoptosis 
 
4.1 Introduction  
The previous chapter evaluated the method of analysis of redox potential in HeLa 
cells expressing roGFP2 protein. Here that method was used to investigate redox 
potential of cells undergoing apoptosis. Changes in the mitochondrial membrane 
potential, a central mechanism of the intrinsic apoptosis pathway, were studied in 
relation to those occurring in the cytoplasmic redox potential. 
4.1.1 Loss of mitochondrial function and generation of ROS during 
apoptosis 
Activation of the intrinsic pathway is associated with mitochondrial outer membrane 
permeabilisation (MOMP), leading to release of pro-apoptotic factors such as 
cytochrome c and is regulated by the Bcl-2 family of proteins (Figure 4.1).  
 
Figure 4.1 Diagram depicting loss of function of mitochondria during apoptosis. 
Pro-apoptotic Bcl-2 family proteins dimerise and form pores in the OM of 
mitochondria causing the content of IMS to leak to the cytosol. These proteins are 
involved in formation of apoptosome that serves the activation of caspase-9, which 
then directly activates executioner caspases 3 and 7 to complete apoptosis. 
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The interaction between Bcl-2 family members is selective and this provides an 
important mechanistic basis for triggering pro-apoptotic or pro-survival signalling 
pathways. Bcl-2 has been reported to act as an antioxidant [65], thus inhibiting 
apoptosis.  
4.1.2 Caspase-mediated loss of mitochondrial function 
Caspases are another critical group of proteins orchestrating apoptosis. This group of 
enzymes is characteristic of apoptosis and involved in activation (caspases -2, -4, -8, 
-9), and execution (caspases -3, -6, -7) of cell death. They also mediate inflammation 
response (caspases -1, -5).  Interestingly, activator caspases are specifically recruited 
to different sites of cell death – caspase-8 is recruited by death-receptor signalling; 
caspase-2 facilitates genotoxic stress-mediated death; caspase-4 is involved in 
mediating ER-stress-mediated death; caspase-9 is activated by an apoptosome 
(downstream of cytochrome c). Most importantly the major executioner caspase is 
caspase-3 [76]. Circu et al. also reported that staurosporine activates caspase-3 
independently to some degree of caspase-8 and -9 and this is also associated with 
temporal GSH efflux from the cell.[76] 
4.1.3 Apoptosis in relation to redox potential change 
Apoptosis is said to occur when the redox potential reaches its oxidative range i.e. 
when the balance between free radicals and scavengers (antioxidants) is disturbed. 
The depletion of glutathione by active transport away from cellular structures has 
been reported to contribute to oxidative stress [42, 120]. Oxidative stress can then 
trigger the apoptotic process. For example, it has been postulated that the redox 
status of the cysteine residues of the proteins involved in the apoptotic process is 
critical for their function[41] [37]. Consequently, drainage of GSH out of the cell 
leaves only the oxidised form of glutathione disulfide, which will result in an 
increased oxidation of certain pro-apoptotic proteins such as caspases [76].  
 
4.1.1.1 Loss of mitochondrial membrane potential in relation to 
change in redox potential  
It has been reported that depletion of glutathione can trigger a decrease in Bcl-2 
expression [121]. In a highly oxidative environment, the transcription factor p53 
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enhances the expression of pro-apoptotic proteins, especially BH3-domain-only Bcl-
family members, and therefore promotes the intrinsic apoptotic pathway. BAX is 
expressed in response to stress by a p53-dependent mechanism. It undergoes 
conformational change and penetrates through the mitochondrial membrane (Figure 
4.1). As a consequence, cytochrome c is released from mitochondria into the 
cytoplasm and together with pro-caspase-9 and APAF-1 (which activates pro-
caspase-9) forms a complex called the apoptosome. This in turn recruits pro-caspases 
through direct Caspase Recruitment Domains (CARD). As a result, the caspase 
cascade is initiated, culminating in cleavage and hence activation of executioner 
caspases and the demolition of key cellular structures.  
 
4.1.4 Aims and Objectives 
This chapter aimed to identify optimal conditions to study apoptosis in HeLa and 
HeLa-roGFP2 cells in relation to the redox potential.  The outcome of this chapter 
will establish, at the cell population level, the association between changes in redox 
potential and apoptosis progression in these cells. It also aimed to provide the ground 
work for the investigation of a more detailed, low throughput, single-cell based assay 
using SERS nanosensors. 
The first objective was to define biomarkers of apoptosis and to establish a valid time 
course to monitor the process. The second goal was to characterise the intracellular 





In order to detect possible changes in the intracellular redox potential during 
apoptosis, the redox potential was measured whilst monitoring specific apoptotic 
biomarkers.  
4.1.5 Establishing controlled conditions for apoptosis  
Timing is crucial when measuring specific biomarkers of apoptosis. For that reason, 
the first step was to establish in detail the apoptosis kinetics within a population of 
cells using the available biomarkers. The protein kinase inhibitor, staurosporine and 
ultraviolet radiation (UVB) were used to trigger apoptosis of HeLa cells. These two 
methods were chosen as they trigger apoptosis in two independent ways. UV induces 
DNA damage and it is related to extrinsic apoptotic pathway, while staurosporine 
mainly through mitochondrial pathway [122]. 
4.1.6 Staurosporine  
Staurosporine (STS), shown in Figure 4.2, is a natural product commonly used as an 
inducer of apoptosis in cells [76]. It is a non-oxidant compound and non-specific 
inhibitor of protein kinases.  
 
Figure 4.2 Staurosporine structure. 
 
Staurosporine-induced apoptosis of HeLa cells was assessed by examining the 
nuclear morphology over a 6 hour culture period. Figure 4.3A shows an increase in 
nuclear fragmentation over this time course. The dose of staurosporine employed 









Figure 4.3 Apoptosis-associated nuclear fragmentation induced in HeLa cells by 
staurosporine. Quantitative analysis of apoptosis as assessed by nuclear 
fragmentation of DAPI-stained HeLa cells. Exponentially growing sub-confluent 
HeLa cells were cultured with staurosporine (1µM) and after various intervals they 
were fixed and stained with DAPI to reveal the nuclear morphology as indicated in 
panel A with arrows. Results are means ± standard deviations from three independent 



















































4.1.7 UVB-induced apoptosis  
4.2.1.1 UVB  
UV radiation can generate free radicals and ROS, causing oxidative stress and cell 
death. UVB radiation was investigated as an alternative trigger of apoptosis in HeLa 
cells. The cells were exposed to various doses of UVB irradiation and then cultured 
for up to six hours. The cells were fixed 0, 2, 4, and 6 hours after UVB irradiation 
and the induction of nuclear fragmentation was determined (Figure 4.4).   
 
Figure 4.4 Apoptosis-associated nuclear fragmentation induced in HeLa cells by 
various doses of UVB irradiation.  
Exponentially growing subconfluent HeLa cells were subjected to the UVB doses 
shown in the legend and then re-cultured. Quantitative analysis of apoptosis was 
assessed after cells were cultured for up to 6 hours cells following UVB-exposure. 
Cells were fixed and stained with DAPI to reveal their nuclear morphology. Results 
are means ± standard deviation for three independent experiments , with 500 cells 
assessed per experiment.   
 
The condensation and fragmentation of the nuclei was dependent upon the dose of 
UVB irradiation. Initially the no more than 7% of the cells showed the characteristic 
apoptosis-associated nuclear morphology (as shown in Figure 4.3B indicated by 
white arrows; shrinkage, nuclear fragmentation); however, the percentage of cells 






















































UVB (Figure 4.4), with higher doses inducing more cells to undergo morphological 
changes. 
This method of induction of apoptosis was not taken further in the study due to the 
risk of photo bleaching of the roGFP2 protein [123, 124]. As roGFP2 is based on the 
enhanced GFP (eGFP) protein, it has been shown that this might not affect the 
405/488 ratio but to avoid the complications of low signal/high background noise 
alternative methods of apoptosis stimulation were used when continuing this study 
[124]. 
As HeLa cells are deficient in death receptors such as Fas-receptor or TNF-a Related 
Apoptosis Inducing Ligand (TRAIL)-receptor, these cells need to be first sensitised 
with a drug prior to the addition of Fas-ligand or TRAIL [125]. This sensitisation 
would make it difficult to establish whether the redox potential changed in response 
to the extrinsic inducer of apoptosis or the sensitisation with the drug, which would 
not be a true representation of redox potential change. 
Having established the time window and method to induce apoptosis in HeLa cells, 
the activation of caspase-3 and caspase-7 during apoptosis in conjunction with 




Figure 4.5 Morphological changes in HeLa cells undergoing staurosporine-induced apoptosis 
Morphology of HeLa cells cultured alone (top row) or with staurosporine (1µM, bottom row) for periods up to 6 hours recorded using 
an inverted phase-contrast microscope. In the unstimulated cells no difference in cell shape was observed. The pink arrows show 
example of HeLa cells, which are not undergoing any morphological change. Cells are spread, attached to the bottom of the culture 
flask. Cells treated with staurosporine showed progressive shrinkage and development of apoptotic bodies throughout the course of 
apoptotic progression as indicated by black arrows. Representative images from three independent experiments. 
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4.1.8 Activation of effector caspases: caspase-3 and caspase-7 in real 
time 
Caspase-3 is the major effector caspase, synthesised as an inactive zymogen. The 
caspase-3 zymogen is cleaved at the aspartate residues by caspase-9 or caspase-8 
resulting in the removal of the pro-peptide sequence and separation of the two subunits, 
p17 and p12. The removal of the pro-domain promotes the protein’s structural 
rearrangement and increases its enzymatic activity. The two subunits dimerise to form 
an active caspase-3 enzyme [126, 127].  
Caspase-3 recognises the tetra-peptide motif Asp-x-x-Asp and cleaves C-terminal to the 
4th residue. In this study, real time activation of caspase-3 was investigated in order to 
confirm the induction of mitochondria-mediated apoptosis. Activation of effector 
caspase-3 is an important marker of a cell’s commitment to programmed cell death.  
To monitor real time caspase-3 activity, and relate these results to the redox potential in 
further experiments, Caspase-3 CellEvent™ Caspase-3/-7 Green Detection Reagent was 
used, which consists of a four amino acid peptide Asp-Glu-Val-Asp (DEVD) 
conjugated to a nucleic acid binding dye. Upon progression of apoptosis the DEVD 
sequence is cleaved from the dye, this allows the dye to migrate to the nucleus and bind 
to DNA, leading to activation of fluorescence at an absorption/emission maxima of 
~502/530 nm. The fluorescent signal increases relative to the activity of caspases- 3 and 
-7 as the DEVD sequence is a preferential sequence for these two caspases.  
Treatment of HeLa cells with staurosporine resulted in increased caspase-3/-7 activity 
from basal levels of 9.8%±1.8% to 41.5% and 93.9% after 2 hours and 3 hours, 
respectively. The increase in enzyme activity was first observed at 2 hours after 





Figure 4.6 Caspase-3/7 activity in HeLa cells treated with staurosporine 
Exponentially growing sub-confluent HeLa cells were cultured with staurosporine 
(1µM) for the indicated time periods and harvested. Cells were stained with 
CellEvent Caspase 3/7 Green reagent and fluorescence was detected by flow 
cytometry. Results are means ± standard deviations for three independent 
experiments. 
Because the excitation and emission spectra of roGFP2 and the caspase-3/7 detection 
reagent overlap, western blotting analysis was employed to compare the activity of 
caspase 3 between HeLa and HeLa-roGFP2 cell lines (Figure 4.7). The caspase-3 
antibody used in western blotting detects endogenous levels of the inactive caspase-3, as 
well as p17 kDa subunit and 19 kDa form of cleaved caspase-3 as well as inactive. 
Western blotting for caspase-3 protein showed that HeLa and HeLa-roGFP2 cells had 
similar responses. Densitometry analysis confirmed that the cell death process was not 
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Figure 4.7 continued. Caspase-3 activity in HeLa and HeLa-roGFP2 cells 
Western blot analysis for the detection of pro-caspase-3 and its cleaved fragments in 
whole cell HeLa extracts after exposure to staurosporine (1µM) for the indicated 
time periods. Densitometry analysis of pro-caspase-3 was performed using ImageJ 
software; all data points were normalised to 0 time point. Beta-actin was used as a 






























4.1.9 Assessment of cell membrane integrity and phospholipid 
symmetry  
One of the hallmarks of apoptosis is phosphatidyl serine (PS) exposure, which precedes 
plasma membrane rupture. In healthy, quiescent cells PS is non-randomly distributed to 
the inner leaflet of the plasma membrane by an amino-phospholipid translocase. 
However, upon induction of apoptosis this enzyme loses its activity and as a 
consequence, asymmetrical phospholipid distribution becomes altered and PS is 
exposed on the cell surface [128].  
This exposure allows Annexin V (AxV), one of a family of calcium-dependent 
phospholipid-binding proteins, to bind to the exposed PS in a calcium-dependent 
manner (Figure 4.8), and, as a result, induce phagocytosis. Phagocytosis of apoptotic 
cells is driven by many points of recognition between phagocytes and the apoptotic cells 
as there are multiple PS-binding proteins. This PS exposure is assumed to be a limiting 
factor for any inflammatory response [129, 130].  
 
Figure 4.8 Scheme of phosphatidyl serine exposure and Ca2+- dependent Annexin 
V binding.  
Annexin V can be conjugated to one of the fluorescent tags, such as FITC or PerCP Cy 
5.5, making it a useful tool for assessment of apoptosis. It is often used in combination 
with DNA-binding dyes tagged with different orthogonal fluorescent conjugates, to 
assess the stage of apoptosis in a population of cells. 
Thus AxV-binding was used here to assess a further hallmark of apoptosis. It was used 
in conjunction with the DNA-binding dye, propidium iodide (PI), which can only enter 
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cells in which the plasma membrane is porous, thereby allowing discrimination of non-
apoptotic (AxV-/PI-), early apoptotic (AxV+/PI-), late stage apoptotic/necrotic  
(AxV+/PI+) and necrotic (AxV-/PI+) subpopulations.  
Results indicate that cells treated with 1µM staurosporine (38%±9.5%) were in early 
apoptosis (AxV+/PI-) after 2 hours of apoptosis induction (Figure 4.9). 43% of cells 
were in early apoptotic stage at 4 hours staurosporine treatment and this increased 
throughout the time course of apoptosis. There was no apparent evidence of necrosis in 
any of the time points, as there were no cells in AxV-/PI+ quadrant. This indicates that 








Figure 4.9 Analysis of staurosporine-induced apoptosis in HeLa cells by flow 
cytometry of annexin V and propidium iodide binding. Upper panel  (A) shows 
representative dual parameter fluorescence dot plots of cell binding of FITC-labelled 
annexin V and propidium iodide over 6 hours culture with staurosporine (1 M). 
Lower panel (B):  Summary of results (dot plot quadrant percentages, mean and SD) 
from three experiments. The population of necrotic cells (AxV-/PI+) varied between 
























As HeLa cells are adherent cells they may expose phosphatidyl serine upon 
trypsinisation thus become false positive for AxV binding. It was therefore important to 
eliminate false positive populations of cells. Caspase-3/-7 and PI co-staining was used 
to investigate whether the cells were apoptotic and/or necrotic. PI only staining 
indicates that cells are necrotic, which were not observed in this study throughout the 
time-course of staurosporine treatment. Healthy cells with intact membrane undergoing 
apoptosis first become Caspase-3/-7 positive, followed by PI binding to the DNA once 
the cell membrane has disintegrated. This can be observed in Figure 4.10 where after 2 
hours 15.6% of the population is Caspase3/7 positive and PI negative (C+/PI-), 
following the trend of 57.1% after 2 hours through to 79.3% of cells in this quadrant 
after 6 hours of incubation with staurosporine.   
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Figure 4.10 Caspase-3/7 activity (C) and propidium iodide (PI) co-staining of 







Figure 4.10 continued Caspase-3/7 activity (C) and propidium iodide (PI) co-
staining of HeLa cells undergoing staurosporine-induced apoptosis. 
HeLa cell binding of CellEvent caspase 3/7 green reagent and PI over 6 hours 
culture with staurosporine (1 M). Upper panel (A) shows dual parameter 
fluorescent dot plots data and a summary of the quadrant data is given in (B). Blue 
rectangles: C(+), PI(-); red: C(+), PI(+); green: C(-), PI(-); violet: C(-), PI(+).  
Results shown in Figure 4.10 indicate that the cells were undergoing apoptosis: 93.5% 
of cells were caspase 3/7 and PI negative at time zero, which then shifted towards 
activation of caspases. 74.1% of cells were caspase-3/7 positive after four hours of 
exposure to staurosporine. This is in line with annexin V/PI staining, and also shows 
that the majority of the population is in the later stages of apoptosis after four hours.   
From the onset of staurosporine exposure, the population of double positive (C+/PI+) 
cells, demonstrated a linear and rapid increase, with c.3 % observed at 2 hours and 
reaching 26 % by 5 hours, whereas at 6 hours the same subpopulation was reduced from 
26 % to 16 % of cells. The observed trend might be due to cells processing through the 
steps of staining and preparation to flow cytometric analysis. As dead cells are easily 
disrupted with centrifugation steps, this may affect the overall percentage of cells at five 
and six hours of treatment. This indicates that cells at 6 hour time point are very fragile 
and dead rather than apoptotic.  
4.1.10 Detection of mitochondrial membrane potential (ΔΨm)  
An upstream event in apoptosis, by many considered as a point of no return [131], is 
























dependent phase of apoptosis. Once the cell undergoes a significant amount of 
mitochondrial depolarisation it is committed to apoptosis by activating a cascade of 
proteolytic enzymes.  
 
 
Figure 4.11 1H-Benzimidazolium, 5,6-dichloro-2-[3-(5,6-dichloro-1,3-diethyl-1,3-
dihydro-2H-benzimidazol-2-ylidene)-1-propenyl]-1,3-diethyl-, iodide (JC-1). 
Spectra of the JC-1 compound adapted from Di Lisa et al. [132] 
In viable cells, the cationic lipophilic j-aggregate forming dye, JC-1 (Figure 4.11), 
accumulates in mitochondria upon polarisation and in the cytoplasm. In mitochondria it 
emits orange-red light and in the cytoplasm it forms monomers, which emit green 
fluorescence. Upon mitochondrial depolarisation of the mitochondrial membrane during 
apoptosis, JC-1 leaves the mitochondria and in the cytoplasm the dye forms monomers 
which emit green fluorescence [133]. In healthy cells, positive fluorescence in both 
channels is observed. Upon progression through apoptosis, loss of membrane potential 
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results in loss of red fluorescence and appearance of green fluorescence. The results 





Figure 4.12 Changes in mitochondrial membrane potential of HeLa cells 
following culture with staurosporine. 
 Cells were cultured with staurosporine (1 M) for 6 hours and samples were taken at 
various intervals for flow cytometric analysis. Flow cytometry was performed on 
stained cells.  Briefly, cells were treated with 1 µM staurosporine for indicated times 
and then working solutions of JC-1 were added. Approximately 10,000 events were 
analysed for mitochondrial depolarisation at excitation of 488 nm and emissions at 
590 nm (J-aggregates) or 535 nm (monomers). Data was analysed using FlowJo 
software. 
As can be seen from Figure 4.12, a continuous reduction in the red/green fluorescence 
intensity ratio which is associated with mitochondrial membrane potential occurred over 
6 hours in cells treated with staurosporine. Before staurosporine treatment 89 % of the 
cells were double positive, with 10 % of cells with depolarised mitochondria  Two 
hours post staurosporine treatment, approx. 10 % of the cells lost their membrane 
potential, and more and more cells lost their potential over time, until, after 6 hours of 
staurosporine treatment, 90.3 % of the cells had depolarised mitochondria.  
Despite its value, several disadvantages have been reported such as, that JC-1 is better 
suited for end-point measurements, given the time it takes to equilibrate between non-
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aggregated and aggregated forms. In addition, this process is not usually dynamically 
reversible, and thus not allowing for future time-resolved measurements. Another 
drawback of using JC-1 is its false-positive/spurious binding outside mitochondria; this 
might cause a false positive change that is responsive to plasma membrane changes 
[134, 135]. 
For further investigation of the mitochondrial membrane potential, several fluorescent 
dyes were considered, however only tetramethylrhodamine methyl (TMRM) and ethyl 
esters (TMRE) were suitable for this study as they both are reversibly measures 
mitochondrial membrane polarisation. Although both TMRE and TMRM are 
rhodamine-based, TMRM is slower than TMRE to reach equilibrium across an 
electrochemical gradient, requiring a few seconds to a minute longer, however TMRE 
has been reported to be a more potent inhibitor of mitochondrial respiration than 
TMRM [124]. Therefore TMRM was chosen to be used in this study. 
  
Both TMRM and roGFP2 are excited by the 488 nm laser line. The laser line has three 
emission filters: 510 nm (green), 570 nm (yellow/orange), and 670 nm (red/far red). 
Compensation of the two channels, where one dye does not leak to the other channel, 
was performed before each experiment. The emission wavelength of the TMRM dye 
was measured with a 573 nm emission filter, this did not interfere with the emission 
wavelength of the roGFP2 protein (535nm) in the green channel of the flow cytometry 
multiplexing experiments.  
 
Figure 4.13 Tetramethylrodamine, Methyl Ester, Perchlorate (TMRM) 
This cationic lipophilic dye enters the cell in a form of a methyl ester that is hydrolysed 
and converted to tetramethylrhodamine, which can accumulate in the negatively 
charged mitochondrial matrix upon mitochondrial polarisation or depolarisation. To 
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enable a comparison between experiments the cell culture conditions (buffers, 
temperature and sample preparation) used to measure the mitochondrial depolarisation 
with TMRM were the same as had been used when apoptosis was monitored with 
















 Table 4.1 Fluctuation of mitochondrial membrane potential in unstimulated 
HeLa-roGFP2 cells. TMRM positive control conditions (untreated with 
staurosporine). Individual data points taken from seven independent experiments.  
Cells show variability in the levels of mitochondrial membrane polarisation between 
different stages of apoptosis therefore it was important to make sure that they were 
harvested from the log phase of growth (Table 4.1). The experimental data showed that 
when cells were harvested at different confluency, the initial mitochondrial membrane 
potential differed between the control samples. This was also observed in previous 
studies of Morgan et al. who studied the redox potential and the dependability of redox 
potential value in relation to the density of cells [123].  
When undertaking experiments that measure such a delicate parameter as the redox 
potential, one has to remember that the variability in redox potential between samples 
may occur due to experimental procedures. It has been shown previously that passage 
number, seeding density of cells, growth medium composition, mycoplasma infection, 
trypsinisation, and transfection of cells all influence the redox processes and the redox 
potential, thus one has to remember to keep experimental variability between 
experiments as low as possible [123].  
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The use of the TMRM reagent allows for time-resolved imaging, where pre-stained 
cells can be treated and the decrease in intensity is measured over time. When 
measuring redox potential and mitochondrial depolarisation, culture medium without 
phenol red was used, because of the auto-fluorescence of the dye [123][114]. In 
addition, it can also be the source of UV-induced cytotoxic species [124] that 
influence the cells’ ability to undergo apoptosis. TMRM is a sensitive reagent that 
detects mitochondrial depolarisation quicker than JC-1 does. Hence, much shorter 
time points were needed to establish the period for the loss of mitochondrial 
depolarisation. Also, these studies  will allow for establishment the sequence and 
correlation of redox potential change versus mitochondrial depolarisation. 
 
  
Figure 4.14 Changes in mitochondrial membrane potential measured with 
TMRM in HeLa-roGFP2 cells undergoing staurosporine-induced cell death time 
course measured in hours. First sample being control (c). Error bars indicate SEM 
of three independent experiments. 
 
Mitochondrial depolarisation was detectable 15 minutes after exposure to staurosporine, 
when the proportion of cells with depolarised mitochondria had increased by 90% 
compared with untreated controls (Figure 4.14). Up until the two hour time point the 
variance of the means shows that the fluctuation is not statistically significant 
(F(3,8)=3.306, p = 0.078). The 2 hour time point marked a rapid increase in the 
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measured values (6.4-fold increase). By 4 hours mitochondria were depolarised in 
86.8% ±3.7% of the cells. Previously reported fluctuations of mitochondrial swelling 
and contraction, are reported by Scarlett et al. [136]. 
 
4.1.11 Establishing the sequence of apoptotic events in HeLa cells  
4.1.12 Annexin V binding to PS precedes caspase 3/7 activation 
In order to establish the sequence of apoptotic events, each dye was compared with each 
other in the same cells. The sensitivity of the various assays needs to be taken into 
consideration when measuring the dynamics of the process and establishing the 
sequence of events. 
This study shows that PS exposure precedes caspase 3/7 activation since 84% ± 3.37% 
of cells were active caspase 3/7 negative and annexin V negative in the untreated 
control, which is characteristic of healthy cells (Figure 4.15). Two hours after 
staurosporine treatment the population of cells had a similar distribution of cells in all 
quadrants: 32% of cells were caspase 3 positive and annexin V positive, while c.30% of 
cells were caspase 3 negative and annexin V positive. Furthermore, 11% of cells still 
remained caspase 3 positive and annexin V negative and 26.4% of cells were caspase 3 
negative and annexin V negative.  
Combining various fluorescently tagged apoptotic markers allows for precision in 
determining the sequence of apoptotic events. However, one has to be careful to not 










Figure 4.15 Activity of caspases 3 and 7 measured against annexin V binding in 
HeLa cells.  
Cells were co-stained with Annexin V and Caspase- 3/-7 DEVD live cell stain 
following staurosporine treatment. Upper panel (A): representative dot plots of 
AxV/caspase3/7 staining. Lower panel (B): mean percent of cells averaged from 
three independent experiments. Bar chart summarises the tendency of cells’ 
























4.1.13 Caspase 3 and 7 activity is preceded by mitochondrial 
depolarisation 
Comparison of two datasets: showing annexin V and caspase 3 activities, suggests that 
annexin V staining precedes caspase 3 activation at the 2 hour time point. At subsequent 
time points a clear trajectory was observed, where the already dominant C+/A+ segment 
of cells was further populated by AxV+ cells. At the terminal time point of 6 hours, the 
overall majority of cells (90.1%) were found in the C+/A+ quadrant, with 9.4% C+/A- 
and the residual 0.5% were shared between the other two quadrants. 
A. 
 
Figure 4.16 Caspase-3/7 activity (C) and mitochondrial depolarisation (T) co-






FIGURE 4.16 continued Caspase-3/7 activity (C) and mitochondrial 
depolarisation (T) co-staining of HeLa cells undergoing staurosporine induced 
cell death. 
Analysis of the effect of 1µM staurosporine on progression through cell death by 
flow cytometry using cells co-stained with caspase-3 (C) and TMRM (T). The upper 
panel (A) shows representative data and the lower panel (B) summarises the 
experiment in a bar chart. Blue rectangles: caspase positive (C+), TMRM negative 
(T-); red rectangles: C(+), T(+); green rectangles: C(-), T(-); violet rectangles: C(-), 
T(+). 
 
Figure 4.16 shows clearly that cells with depolarised mitochondria and active caspase -3 
were observed by 3 hour post-staurosporine exposure. However, the data suggests that 
the mitochondrial depolarisation precedes caspase -3/ -7 activity which is in line with 
the literature which reports that the activity of caspase -3/ -7 (effector caspases) is 
preceded by the loss in mitochondrial membrane potential [137].  
  
control 2 3 4 5 6
C-/T+ (%) 87.1 49.0 6.9 0.8 0.2 0.1
C-/T- (%) 3.2 14.8 5.4 1.0 0.8 1.2
C+/T+ (%) 3.2 17.5 31.5 21.7 11.9 3.8




















Staurosporine treatment [hours] 
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4.1.14 Mitochondrial depolarisation precedes Annexin V binding to PS 
 
Characteristic morphological and biochemical changes distinguish apoptosis from 
necrosis. In viable cells PS is located in the innerspace of the cell membrane, however 
upon loss of the membrane symmetry, the PS is exposed to extracellular space allowing 
Annexin V binding. High mitochondrial membrane potential is characteristic to healthy 
cells and it diminishes while cells undergo apoptotic changes.  In order to confirm the 
sequence of events the phosphatidyl serine exposure and mitochondrial depolarisation 
were measured [138]. To date it is not clear what exact mechanism causes phosphatidyl 
serine residues to be exposed at the surface of apoptotic cell, however studies from C. 
elegans suggest that this is the direct consequence of caspase cleavage. Since caspase 
activity os direct consequence of mitochondrial depolarisation it is suggested that the 
Annexin V will follow the mitochondrial depolarisation [138]. 
A healthy HeLa population is characterised by the dominance of cells with a strong 
TMRM signal, pinpointing active and polarised mitochondria, and absence of PS from 
the cell surface. Dominance of such cells is seen in untreated and STS-exposed samples, 
treated for 1 hour (Figure 4.17, lower panel). Following 1 hour exposure to STS, 
Annexin V negative and TMRM positive cells (AxV-/T+) depleted from 64.6% down to 
56.1%. During the following 5 hours the percentage of AxV-/T+ phenotype decreased 
progressively such that by 6 hours only 0.3% of the cells were AxV-/T+ indicating that 
mitochondrial depolarisation precedes the PS exposure in the first two hours of 
apoptosis triggered by staurosporine, following the trend and after six hours 74% of 
cells showed mitochondrial depolarisation and PS exposure. 
After 2 hours, the rate of loss of the TMRM signal increased, indicating depolarisation 
of the mitochondria. After 6 hours 98.9% of cells demonstrated an absence of TMRM. 
At 4 hours, TMRM-negative cells in the majority were also AxV-negative (74%). It can 
be concluded that mitochondrial depolarisation, as a key step in apoptosis, is taking 








Figure 4.17 Annexin V and mitochondrial depolarisation co-staining of 
HeLa cells undergoing staurosporine induced cell death. 
Analysis of the effect of staurosporine on progression through cell death by flow 





0.5 1 2 4 6
AxV+/T- 9.9 7.2 8.0 8.0 16.7 40.8
AxV-/T- 15.7 27.0 24.9 42.6 74.0 58.1
AxV+/T+ 9.8 6.7 11.0 11.1 3.9 0.8



























4.1.15 Redox potential change is preceded by Annexin V binding  
It is still a matter of debate whether the redox potential is a cause or a consequence of 
apoptotic events. The work in this chapter investigated the redox status of the 
intracellular environment by monitoring the oxidation state of roGFP2 which has been 
stably transfected into the HeLa cells. In order to establish whether the shift of redox 
potential towards a more oxidative range, in cells undergoing apoptosis, is linked to 
other functional changes in the cell the comparison of redox potential with AxV, 
mitochondrial depolarisation, and caspase-3 activity was used.  
A multiplexing experiment by flow cytometry recording simultaneously multi-
parameters, including reduced and oxidised ratio of roGFP2 combined with other 
apoptotic hallmarks, for individual cells allowed for discrimination and determination 
of the sequence of events across the cell population. The data shown in Figure 4.18 










Figure 4.18 Measurements of redox potential (R – reduced; O – oxidised) along 
with annexin V (AxV) binding in HeLa-roGFP2 cells treated with 
staurosporine for the indicated amount of time (hours). Dot plots (A) are a 
depiction of one experiment, whilst bar charts (B) are a depiction of three 
independent experiments and error bars indicate SEM. 
untreated 2 h 4 h 6 h
AxV-/O (%) 5.7 4.8 11.7 16.4
AxV-/R (%) 66.9 46.0 35.2 8.7
AxV+/O (%) 8.7 9.7 23.0 58.9






















Multi-parametric and simultaneous analysis of redox potential and AxV binding in 
HeLa-roGFP2 cells was performed at four time points (Figure 4.18). In the absence of 
staurosporine treatment, the cell population was dominated (66.9%) by cells not 
expressing phosphatidylserine (PS), indicating an AxV negative status, and being in a 
reduced state. The parametrically-opposite cell population, being AxV positive and in 
an oxidised state (A+/O), was represented by 8.7% of cells.  
Two hours exposure to staurosporine markedly reduced the total pool of AxV-negative 
cells (from 72.6 % to 50.8%). However, the joint redox potential remained unaffected 
(85.6% in untreated samples and 85.5% after 2 hour exposure).  
During the next four hours of exposure to staurosporine, a shift in cell distribution was 
observed. At 6 hours a 6.8-fold increase in AxV-positive and in oxidised state cells was 
noted, making this subset of cells the prevailing group (58.9%). Furthermore, after 6 
hours the total number of cells demonstrating an oxidative status was 65.3%, a 4.5-fold 




4.1.16 Redox potential change is preceded by loss of mitochondrial 
membrane potential 
To observe the progression of mitochondrial depolarisation as one of the central 
apoptotic events, in combination with changes in redox potential, a multiplexing study 
was performed (Figure 4.19).  The untreated samples were dominated by cells with 
polarised mitochondria (TMRM-positive (T+)) and in a reduced state (73.7%), which is 
characteristic of a healthy cell. Whereas the contrary parameters (TMRM-negative (T-) 
and in oxidised state) were observed in 10.5% of cells in the same samples. 
A. 
 
Figure 4.19 Redox potential (oxidised and reduced states) against 






FIGURE 4.19 continued. Redox potential (oxidised and reduced states) against 
mitochondrial depolarisation in HeLa–roGFP2 cells. Upper panel (A), an example 
of mitochondrial depolarisation and redox change in HeLa roGFP2. Lower panel 
(B), chart summary for three independent experiments. In untreated sample 73.7 % 
of cell population are in the TMRM positive and reduced range of redox potential 
quadrant. Upon induction of apoptosis by staurosporine there is a visual shift in 
trend of cells being still TMRM positive, but more oxidising range of redox 
potential, this trend prevailed until around 2 hour time point. After this time point 
cells with depolarised mitochondria and reductive redox potential range subsitised 
48.1 % of the population while depolarised and oxidised range was 30.4 %. This 
trend prevailed through to the last time point where 28.4 % of the population was T-
/R and 62.2 % were T-/O .  
During the first 2 hours after exposure to 1µM staurosporine three analyses were 
performed (at 0.5, 1 and 2 hours). During this time a healthy cell phenotype (T+/R) was 
still dominant, but gradually reducing from 59% to 53% of the population. 
Concurrently, acceleration in mitochondrial depolarisation was also observed, where the 
population of T- cells in a reduced state underwent a 4.8-fold increase (from 4.2% in 
untreated samples to 20.2% at 2 hour point). 
The most prominent shift from a healthy cell phenotype to the majority of cells with 
depolarised mitochondria (T-) occurred during the following 4 hours of exposure to 1 
µM staurosporine. By the 4 hour time point, 78.5% of the cell population had 
untreated 0.5 h 1 h 2 h 4 h 6 h
T-/O (%) 10.5 12.7 14.8 14.5 30.4 62.2
T-/R (%) 4.2 7.2 7.9 20.2 48.1 28.4
T+/O (%) 11.6 21.1 24.2 11.6 2.8 2.0






















depolarised mitochondria, and by the 6 hour time point an oxidised sub-population with 
depolarised mitochondria were representing the majority of cells at 62.2%.  
Summative analysis of T- (irrespective of redox status) and oxidised cells (irrespective 
of mitochondria’s status) showed that T- cells were starting to dominate (≥ 50%) the 
cell pool at the 4 hour time point, and oxidised cells (O) became dominant at the 6 hour 
time point. This observation identifies mitochondrial depolarisation as an earlier event 
than oxidation in the apoptosis cascade. The same observation was confirmed by 
analysis of individual, not multiplex, channels for T+/- and O/R (data not shown).  
This observation indicates that the change in redox potential triggers the initial 
depolarisation of the mitochondria, however after the prolonged mitochondrial damage; 
the content from the mitochondria leaking to the cytoplasm might have changed the 
overall redox potential indicated by the change in the shift. The redox potential in the 
cells was being progressively oxidised.  
4.1.17 Redox potential in HeLa-roGFP2 is independent of 
mitochondrial membrane depolarisation  
In order to test the hypothesis that the redox potential is influenced by the loss of 
mitochondrial membrane potential, Bongkrekic acid (Figure 4.20) was used to inhibit 
mitochondrial permeability transition pore opening.  
 
Figure 4.20 Bongkrekic acid scheme  
Bongkrekic acid (BKA) is a specific ligand of adenine nucleotide translocase (a 
component of the mitochondrial permeability transition pore complex) and fixes its 
conformation in the m-state [128]. It prevents mitochondrial depolarization, swelling, 
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rupture of the mitochondrial outer membrane, and release of apoptogenic proteins such 
as cytochrome c. It has been used in various studies using staurosporine induced 
apoptosis in Jurkat cells or by hypochlorous acid in hepatoma HepG2 cells [139][129]. 
 
 
Figure 4.21 Nuclear fragmentation in cells pretreated with BKA or 1 µM 
staurosporine only in HeLa-roGFP2 cells. Where indicated, the cells were 
pretreated for 1 hour with bongkrekic acid (BKA, 100 µM), washed and then 
stimulated with staurosporine (1 M).  
 
During the first 2 hours of exposure to STS both BKA-pretreated and BKA-free HeLa 
cells transfected with roGFP2samples demonstrated a linear increase in apoptotic cell 
number, from 3.4% to 19.2% and from 6.3% to 36.3% at 0 and 2 hours, respctively . 
However the rates of increase were not the same due to the effect of BKA. Smaples not 
pre-treated with BKA demonstrated 3.4, 2.4 and 1.8-fold higher difference in the 
number of apoptotic cells at 15 minutes, 1 and 2 hours respectively.  
In the following 2 to 4 hours apoptosis progressed promptly, with 58.8% of the BKA-
































timepoint, which represented a 3.1-fold increase in comparison to the 2 hour timepoint. 
At the same time, non-pretreated staurosporine only samples exhibited continued linear 
gowth trajectory in apoptotic cell numbers, representing  78.9% of cell population at 4 
hours. 
Rapid acceleration of nuclear envelope fragmentation after 2 hours of exposure to STS 
indicated a reduction in the apoptosis-protective properties of BKA (after 1 hour of pre-
treatment). In addition, it is widely known that mitochondrial depolarisation happens 
before nuclear fragmentation in the apoptotic cascade. Therefore, this study showed that 
apoptosis is delayed after pre-treatment with BKA, this was due to a delay in 
mitochondrial depolarisation (Figure 4.21).  
This data showed that nuclear fragmentation was delayed in the first two hours in cells 
pretreated with Bongkrekic acid: 19.2%±5.8% of cells were apoptotic, while 
36.34%±1.6% cells were apoptotic in staurosporine only treated cells. This corresponds 
to 78.8%±5.13% of cells with a fragmented nucleus at 4 hours post-staurosporine 
treatment and 58.5%±9.6% of cells with Bongkrekic acid pretreatment.  
4.1.18 Mitochondrial depolarisation in HeLa and HeLa-roGFP2 
To gain a more accurate understanding of the timing of the apoptotic process in HeLa 
cells after roGFP2 transfection, apoptosis was triggered by STS and changes in the 
mitochondrial polarisation were assessed. In addition, it was important to see if the 
miotochondrial polarisation status, one of the key markers of apoptosis, was affected by 
the transfection. Therefore, HeLa and HeLa-roGFP2 were investigated.  
Mitochondiral polarisation was assesed by tracking TMRM fluorescent signal loss after 
exposure to 1 µM STS for up to 3 hours (Figure 4.22). As in the above experiment, half 
of the samples were pre-treated with BKA for 1 hour. 
After 15 minutes and 1 hour of exposure to STS, the variance of the means between  
parental HeLa and HeLa-roGFP2, with and without BKA pre-treatment, was equal 
across the four treatments, according to one-way ANOVA (15 minutes: F(3,8)=2.52, 
p=0.132; 1 hour: F(3,8)=2.51, p=0.132). However, at the 2 hour time point BKA pre-
treatment had a significant effect on the mitochondrial depolarisation rate, both in 
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parental and roGFP2-transfected HeLa cells (F(3,8)=10.01, p=0.004), when compared 
to non-pretreated samples (HeLa: p=0.025; HeLa-roGFP2: p=0.016). Further 
comparison between HeLa and HeLa-roGFP2, at respective conditions, did not find 
significant differ at the 2 hour time point (p=0.253).  
The observed results, taken together, confirmed the effect of BKA on mitochondrial 
depolarisation both in HeLa and HeLa-roGFP2. In addition, the close to identical 
response of parental and roGFP2-transfected cells to STS, as analysed through loss of 











Figure 4.22 continued Tracking of mitochondrial depolarisation in HeLa and 
HeLa-roGFP2 cells, during exposure to STS.  Half of the cell samples were pre-
treated with 100µM BKA for 1 hour prior to STS treatment. During 1 hour of STS 
exposure, variance of the means in four conditions remained equal (n.s.) 
(F(3,8)=2.51, p=0.132). The effect of BKA in the attenuation of mitochondrial 
depolarisation was clearly observed after 2 hours of STS exposure (HeLa: p=0.025; 
HeLa-roGFP2: p=0.016). No difference in mitochondrial activity was observed 
between HeLa and HeLa-roGFP2, in both BKA-pretreated and non-treated samples 
(p=0.684 and p=0.253, respectively). One-way ANOVA and equal variance t-test, 
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Figure 4.23 Redox potential change measured with roGFP2 stably expressed in 
HeLa population of cells undergoing apoptotic cell death.  
No difference in the redox potential was observed between the control sample and 
staurosporine-treated samples up to four hours of exposure. The redox potential was 






4.1.20 Redox potential change in apoptosis and mitochondrial 
depolarisation 
To assess a possible link between mitochondrial depolarisation and redox potential 
changes during apoptosis, one set of samples was pre-treated with BKA to delay 
mitochondrial depolarisation. During 3 hour exposure to STS and tracking changes in 
redox potential through roGFP2, a linear change trajectory towards oxidative state was 
observed, in both non-treated and BKA pre-treated samples (Figure 4.24).  
Work in this thesis also provides validation of use of roGFP2 as a measure of redox 
potential at the population level. This has been done to achieve a standard curve for 
roGFP2, measured by flow cytometry. The data showed that the mid-point potential of 
roGFP2 is -285 mV, which is in accordance with literature reports for roGFP2 [107, 
140].  
The redox potential in apoptosis change spans 25.4 mV (from -314.3 mV to – 288.9 
mV), as shown in (Figure 4.23, Chapter 4). It has been shown here that at one hour of 
the exposure of PS the redox potential is -306.37±15.4 mV. The redox potential change 
is not significant during the first four hours of treatment with staurosporine.  
However, one-way ANOVA analysis has indicated that cells which were not pre-treated 
with BKA do not experience change in redox potential, after exposure to STS (F(3,8) = 
1.832, p = 0.219). Whereas, BKA-pretreated cells did show significant difference 
between the means (F(3,8) = 5.316, p = 0.026) - means of 15 minute and 3 hour time 
points were found to be significantly different (p = 0.026). This observation suggests 
that the trend is fluctuating, although this may be because of the effect of mitochondria 





Figure 4.24 Time course analysis of redox potential change in HeLa-roGFP2 
cells during exposure to 1 μM STS. Half of the cell samples were pre-treated with 
100 μM BKA for 1.5 hours prior exposure to staurosporine. Three independent 
experiments. Error bars representing SEM, *p<0.02. 
One-way ANOVA analysis has indicated that means of BKA pre-treated cells at four 
hour time points, when treated with STS, were not equal (F(3,8) = 5.316, p = 0.026). 
Equal variance t-test was used, as individual samples were used for every time point. 
Means of 15 minute and 3 hour time points were found to be significantly different (p = 
0.026; (*)). One-way ANOVA test found non-pretreated cells to have equal means 
(non-significant difference, n.s.), when exposed to STS (F(3,8) = 1.832, p = 0.219).  
These results suggest that the redox potential measured by roGFP2 at the population 
level does not change significantly throughout apoptosis. However, treatment with BKA 
has been shown to change the redox potential significantly. Mitochondrial 
depolarisation does not contribute to changes in the redox potential and this is indicating 
that the cellular redox is more oxidative independently of mitochondrial transition pore 































4.3 Conclusions  
The results of this section can be summarised as follows:  
 Cells undergoing staurosporine-induced cell death displayed typical apoptotic 
morphology;  
 The order of apoptotic events was determined to be as follows: phosphatidyl 
serine exposure, mitochondrial depolarisation, followed by caspase 3/7 
activity. 
The mechanism of staurosporine-induced apoptosis in cells is a subject of debate [141, 
142], as both involvement of caspase-dependent and caspase-independent pathways 
have been described [110][102]. Nicolier et al. reported that staurosporine initially 
induces death of HeLa cells via cytochrome c release from the mitochondria, followed 
by activation of caspase-9 and caspase-3. Nevertheless, a delayed caspase-independent 
pathway may also be present [110]. 
In addition, it has been shown previously that staurosporine induces cell death through 
formation of reactive oxygen species. A study by Circu et al[76] showed that the cell 
death induced by staurosporine was in fact preceded by GSH efflux and activation of 
caspase-3. These changes were independent of the cellular redox status of total GSH 
and total GSSG measured by HPLC.  
An increase in activity of active caspase-3 after 4 hours of exposure to staurosporine 
was observed. At the same time there was a caspase-3 complex forming, which 
appeared to be a high-molecular-weight complex (around 64 kDa) of caspase-3. The 
data from western blotting suggests that the subunits formed a quadruple procaspase-3 
complex. Caspase-3 complex formation of much higher molecular weight was 
previously reported in rat brain tissue [16], and caused by starvation [17]. One of the 
explanations for complex formation at the later stages of apoptosis might be due to 
cysteine oxidation driving the formation of complexes. As the redox potential becomes 
more oxidative over the time course of apoptosis, the oxidation of active site cysteine 
residues might influence the formation of such 64 kDa complex (miss folding of the 
complex). This results in decreased activity of caspase-3 as previously reported by 
Aucheviole et al[99]. 
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The western blotting investigation of active caspase-3 revealed that there was no 
difference in the apoptosis progression between the HeLa and HeLa-roGFP2 cells, 
suggesting that the caspase activity measured by the CellEvent™ Caspase-3/7 Green 
Detection Reagent has the same dynamics as the caspase-3 activity in HeLa-roGFP2 
cells. 
The high percent of AxV-positive cells in the untreated population makes the data 
difficult to interpret and suggests a flaw in the method employed. Indeed, the 
detachment of cells with trypsin can result in false positive population of cells, where 
phosphatidyl serine flips to the outer layer of membrane upon stimulation with trypsin. 
This study employed use of a milder EDTA only detachment reagent called Versene 
from Thermofisher. However, the amount of AxV positive cells was still high for the 
population of HeLa cells. Phosphatidyl serine may be exposed on the outer membrane 
when trypsinised and the cells might be false-positive for AxV binding even though 
they are not apoptotic.  
HeLa-roGFP2 cells do not show a difference in staurosporine-induced apoptotic 
progression when compared to non-transfected cells. HeLa-roGFP2 cells show a 
tendency towards oxidative redox potential change throughout apoptosis.  
BKA is reported to have a biphasic effect on MPTP; in the first minutes after 
application it stabilized the mitochondrial membrane, followed by a pronounced 
opening of PTP. BKA is also reported to inhibit MPTP pore opening in response to pro-
oxidants and protonophores, but failed to interfere with MPTP induction by Ca2+ and 
chemical thiol crosslinking [143].  
BKA is also reported to prevent events linked to apoptosis such as: depletion of reduced 
glutathione, generation of reactive oxygen species, translocation of NFκB, exposure of 
phosphatidylserine residues on the outer plasma membrane, cytoplasmic vacuolization, 
chromatin condensation, and oligonucleosomal DNA fragmentation [143].  
Data from Figure 4.18 and Figure 4.19 shows that rise in redox potential is associated 
with a later onset of apoptotic events and it occurs after mitochondrial depolarisation. It 
thus might be influenced by the loss of mitochondrial membrane potential. 
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This data shows that redox potential in HeLa-roGFP2 cells rises independently of 
mitochondrial depolarisation. BKA pre-treatment of cells showed no significant 
difference in rise in redox potential between cells undergoing staurosporine-induced 
apoptosis. Even if mitochondrial depolarisation was inhibited, redox potential in cells 
pre-treated with BKA progressed at the same rate as in staurosporine only treatment. 
This suggests that there is no effect of mitochondrial depolarisation, on redox change 
through apoptosis.  
 
Figure 4.25 Summary view of key apoptotic events in HeLa cells. Events are ordered 
from left to right as they occur in the cell. Displayed are summary data from Chapter 4. 
The data shows percent of cells at each stage of apoptosis with exposed 
phospohatidylserine (AxV +ve), polarised mitochondria (ΔΨm), activity of caspases 3 
and 7 (caspase 3/7), fragmented nucleus (nuclear fragmentation). Redox potential was 
measured by roGFP2. 
However, roGFP2 is reported to not be responsive to any pH change within the 
physiological range, and previously reported studies show that pH becomes more 
alkaline when cells undergo apoptosis. Still, there is no evidence that this acidification 
is due to mitochondrial depolarisation.   
Flow cytometry analysis was used to investigate the collective behaviour of individual 
cells (Figure 4.25). Each cell was labeled with an apoptotic marker and this was 
examined via flow cytometry, which gave an insight into the dynamics of the apoptotic 
processes at the population level. However, there was some variability between 
experiments as well as between the control samples. This indicates that the study of 
variability between single cells is required to further understand whether this subtle 
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effect was caused by the variability between conditions of the experiment or the 
representation of variability between the cells in a given population (Figure 4.25).  
Flow cytometry data gives more information regarding single cell behaviour than the 
fluorescence plate readouts. This is due to the type of data acquired from each 
technique. The plate reader gives data in batch of the population of the cells in the well; 
however it is an average of the readout that is the final result, not giving the information 
on the single cells. Thus, this might not be representative of the variability between the 
cells in the population as presented by various studies.  
Thus, in the following chapter each cell was treated as a single experiment, and the 
variability between experiments was determined. This may have a potential for use in 
monitoring of single cells’ resistance to undergoing apoptosis and in consequence 
detection of a single cell that evades apoptosis. As suggested by Meyer et al. the redox 




Chapter 5  
Investigation of redox potential change in apoptosis at 
the single cell level 
 
5.1 Introduction  
The findings presented in Chapter 4 suggested that changes in the redox potential are 
associated with apoptosis since the redox potential shifts towards a more oxidative 
range when cells are undergoing programmed cell death. Results of the high throughput 
studies at a population level suggested that the rise in redox potential occurs 
independently of mitochondrial depolarisation; however, it is not clear whether it is a 
cause or a consequence of the apoptotic process.  
It has been previously reported that the cytoplasm undergoes substantial acidification 
upon induction of apoptosis in various cell lines such as human T lymphocyte Jurkat 
cells [134] and Human promyelocytic leukemia HL-60 cells (pH 7.8 to pH 6.2) [144]. 
Acidification of the cytoplasm has been reported to occur concurrently with 
phosphatidyl serine exposure [145]. At the same time, anti-apoptotic Bcl-2 has been 
shown to be upstream of the acidification, thus protecting cells from apoptosis. 
Acidification can also be prevented by z-VAD-fmk, a non-specific protease inhibitor, 
suggesting that acidification is a consequence of protease switches [145]. These studies 
used flow cytometry, where a trend in a population was measured, but not exact values 
of pH. For the purpose of measuring redox potential, it is important to measure the pH 
quantitatively since an increase in 1 pH unit results in a change of redox potential of 
59.1 mV at 298 K according to the Nernst equation. Common methods used to quantify 
the pH in cells use a fluorescent dye followed by incubation with nigericin and 
potassium ions at various external pH’s between 6.5 and 8.8. [146]  
 
The flow cytometry method developed in Chapter 4 is of advantage to investigate the 
single cells at a high throughput thus showing the overall trend of the population, but 
single cell resolution together with assay sensitivity might be lost and it is difficult to 
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establish whether the oxidative change is a trigger of mitochondrial depolarisation or 
vice versa. While roGFP2 reports on relative GSH/GSSG ratios, it is dependent on the 
activity of Grx-1 enzyme, which may delay the response to redox change in the 
environment couples such as NAD(P)H/NAD(P)+ and does not take into account 
changes in pH. roGFP2 therefore may not give a truly quantitative representation of the 




Work in Chapter 5 aims to quantitatively measure the redox potential and pH in real 
time by surface enhanced Raman spectroscopy (SERS). To investigate the relationship 
between the redox potential and apoptosis at the single cell level a novel method 
established by the Campbell lab employing redox-responsive nanosensors was used 
[98]. This relies on quinone-based reporter molecules to quantitatively measure the 
redox potential in real time by SERS.  The method offers a potentially more reliable 
alternative to fluorescence-based techniques, especially for the early events of 
apoptosis, due to a more rapid response time, the ability to measure an overall potential 




5.1.2 Raman spectroscopy  
Recent years have seen several new techniques for the investigation of cellular 
processes at a single cell level [147-149]. One such technique, Raman Spectroscopy, 
utilises marker-free optical technology enabling the observation of a range of cellular 
processes including discernment of cell death pathways [150]. 
Raman spectroscopy gives information about the structural properties of molecules 
based on their vibrational and rotational transitions. Each molecule has its own 
vibrational signatures, determined by atoms and individual bonds in the molecule and 
each molecule thus has a characteristic Raman spectrum. Raman spectroscopy measures 
the shift in frequency of photons as a result of inelastic scattering. [151] 
 
 
Figure 5.1 Jablonski diagram depicting Rayleigh and Raman scattering of the 
incident photon:  the molecule can relax back down to the ground state and emit a 
photon of equal energy (Rayleigh scattering); the molecule can relax to a “real” 
vibrational state and emit a photon with less energy than the incident photon (Stokes 
scattering); the molecule is already in an excited vibrational state and is excited to a 
higher virtual state and then relaxes back to the ground state emitting more energy than 
that of the incident photon (anti-Stokes scattering). 
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When incident light interacts with a molecule it induces a dipole moment and the light 
is scattered. A Jablonski diagram (Figure 5.1) describes the quantum energy transitions 
for both Rayleigh and Raman scattering of incident photons. Rayleigh (elastic) 
scattering dominates the effect and does not result in a change in frequency of the 
scattered light.  
Raman (inelastic) scattering occurs in only 1 in 108 of the incidence photons [152] and 
shifts the frequency of incident light by increasing (anti-Stokes) or reducing (Stokes) 
the frequency of the photon. The Raman effect provides a means of directly measuring 
the vibrational frequency of a molecular bond because the incident photon changes 
energy by the same amount as required to excite the vibrational transition. The Raman 
spectra are plotted as intensity versus frequency diagrams depicting energy levels of 
vibrations of different functional groups.  
Raman spectrometry is attractive for analysing vibrational transitions in molecules of 
interest within intracellular environments: it does not suffer from interference from 
water in the way that infrared spectrometry (IR) does; and by tuning the laser excitation 
wavelength background fluorescence can be minimised. 
Even though it is often possible to qualitatively and quantitatively assess a molecule of 
interest with Raman spectrometry, this process becomes substantially more difficult in 
biological samples (i.e. non-fractionated cells) due to the number of molecules 
(deconvolution options are limited) and low signal intensity (high noise/signal ratio). To 
overcome this hurdle, conjugation of the target molecule to silver or gold nanoparticles 
causes amplification by as much as a factor of 1014 [153]. This method of signal 




5.1.2.1 Surface Enhanced Raman Spectroscopy 
 
While Raman spectroscopy has been successfully applied to biological systems to 
investigate the difference between healthy and diseased cells [152] spontaneous Raman 
spectra usually suffer from low intensity. Recently, SERS which uses the property of 
surface plasmon resonance to amplify the signal of a molecule that is in close proximity 
to their surface, has been successfully applied to biological systems [154, 155]. The 
amplification of the signal has been reported to be as high as 1012 if the molecule is 
adsorbed on a nanoparticle’s noble metal surface and the particle is spherical or rod-
shaped. [154] After the initial discovery of SERS in 1973, an extensive number of 
studies have shown applicability of this method for human tissue analysis [154, 155]. 
5.1.2.2 SERS nanoparticles 
The nanoparticles used in this study had a 120 nm diameter silica core and were coated 
with an outer layer of gold giving approximately 150 nm total diameter (Figure 5.2).  
 
Figure 5.2 The structure of nanosensor (in this case NQ-NS). 
These gold nanoshells (NS) have been identified as an attractive material for application 
in biological systems [156] as they are biocompatible and have tunable plasmon 
resonance between 780 nm and 820 nm (near infrared, NIR). NIR compatibility is 
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desirable for biological SERS measurements because there is less intrinsic fluorescence 
from cells and tissues in this region of the spectrum. These gold nanosensors do not 
aggregate and are easily absorbed by entocytosis by the cell; therefore, they are suitable 
to conduct cytoplasmic measurements of redox potential. However, the size of the 
nanosensor might be problematic when measuring redox potential in other 
compartments (such as nucleus, mitochondria), as these sensors are larger than the pores 
they could potentially enter through. The ongoing work in the Campbell’s lab 
investigates different types of the nanosperes and nanorods to enable further studies, 
however the current issue is the tendency of nanorods to aggregate within the cells’ 
cytoplasm close to targeted compartment (data not shown). 
5.1.2.3 Redox responsive molecules 
Two redox molecules designed by Campbell’s lab have been used in this study:  
1) 1,8-diaza-4,5-dithian-1,8-di(2-chloro-[1,4]-naphthoquinone-3-yl)octane  (NQ).  
2) N-[2-(disulfanyl)ethyl]-9,10-dioxo-9,10-dihydroanthracene-2-carboxamide (bis-
(2-Anthraquinone carboxamide) (AQ).  
These molecules can be reversibly reduced and oxidised in response to changes in the 
redox environment (FIGURE 5.2 and FIGURE 5.3). [99, 157, 158][97, 149, 150] 
It has been reported previously that Density Functional Theory (DFT) calculations 
corresponded with observed spectroelectrochemical data and pinpoints signals that 
change in response to variable redox potentials. Therefore the redox potential reported 
by the molecule is highly dependent on the environment surrounding the molecule.  
Reduced and oxidised states of AQ and NQ molecules used in this study differ in 
optical properties and these changes can be depicted in SERS spectra (Figure 5.3 and 
Figure 5.4 lower panels). For the AQ reporter, the ratio of signals at 1666 cm-1 (C=O 
stretching in oxidised) and 1606cm-1 (constant C=C stretching in both reduced and 
oxidised forms) measured at a range of potentials was used to construct a calibration 
curve (Figure 5.3). AQ-NS covers a working range of redox potentials spanning from -





Figure 5.3 Structure of reporter molecule (AQ) in reduced and oxidised form 
assembled on gold surface of a nanosphere. A. Calibration curve adapted from Jiang 
et al. [138]. B. Example of a Raman spectrum of AQ-NS in cells. Acquisition time 30 
seconds and 785 nm laser at 10% power. For AQ molecule the redox potential is 
calculated from ratio of signals at 1666 cm-1 (C=O stretching in oxidised) and 1606cm-1 







Figure 5.4 Reporter molecule (NQ) in reduced and oxidised form on left and right, 
respectively; assembled on the gold nanoparticle (black dot). A. Calibration curve 
for NQ adapted from . B. Example of a Raman spectrum of NQ-NS in cells. For the NQ 
molecule the intensity of signals of 1633 cm-1 (C=O stretching seen only in an oxidised 
environment) and 1579 cm-1 (symmetric ring breathing in both oxidised and reduced 




Peak 1577 cm-1 shows symmetric ring breathing (reduced version of NQ), while peak at 
1633cm-1 corresponds to C=O stretching (reference peak for reduced and oxidised NQ). 
The ratio of two peaks is then applied in the Nernst equation and the redox potential is 
calculated. The measuring range of redox potential of NQ-NS spans from -394 mV to     
-194 mV. 
Both redox reporter molecules used in this study have been previously tested and 
confirmed to be responsive to all thiol based buffers, therefore they were suitable for 
quantification of the overall intracellular redox potential [99, 157]. Those molecules 
were successfully mounted onto the gold nanoshells by sulfur-gold bonds. The 
advantageous characteristic of reporter molecules is that the characteristic Raman shift 
frequencies for distinguishing oxidised from reduced forms of reporter molecule differ 
from the typical vibrational modes of DNA, proteins, and lipids [155]. 
 
Figure 5.5 showing a principle of SERS measurements of intracellular redox 
potential with redox responsive nanosensors. Cell with nucleus (green) and localised 





As previously published by Auchinvole et al. the generation of ROS and the 
upregulation of oxidative stress levels was not detected when nanosensors were 
introduced to the cells, therefore it was concluded that they do not cause toxic effects or 
imbalance the redox status of the cell [99, 159].  
5.1.2.4 MBA-NS - pH responsive sensor  
pH measurements were performed in order to establish a true value of redox potential at 
a particular stage of apoptosis. This is important as the increase in one pH unit 
corresponds to a shift of approximately -59.1mV in potential.  
4-mercaptobenzoic acid (MBA) which is a well-established SERS pH sensor was used 
for this purpose [157]. The SERS spectra of MBA-NS has two signals at 1080 cm-1 and 
1590 cm-1 which are assigned to pH-independent aromatic ring vibration and thus can 
be used as a reference to changing pH signal intensities which are two peaks, the first at 
1400 cm-1 (COO- stretching) and the second at 1700 cm-1 (C=O stretching). The 1400 
cm-1 peak increases with increasing pH, and 1700 cm-1 peak decreases with increasing 
pH. The range of the sensor is between pH 6 and pH 9, making it well suited for 
reporting the cellular pH [100, 157].   
 
 
Figure 5.6 Structure of reporter molecule (MBA) in reduced and oxidised forms, 
assembled on gold nanoshell. A. The plot represents the calibration curve indicating 
the useful pH reporting range between pH 6 and pH 8 [17] and (B) an example spectrum 












FIGURE 5.6 continued Structure of reporter molecule (MBA) in reduced (left) and 
oxidised (right) forms, assembled on a gold nanoshell. A. an example spectrum of MBA 
reporter and (B) The plot represents the calibration curve indicating the useful pH 




5.2.1 Nanosensors do not alter the viability of cells  
It was important to establish, whether the AQ-NS and MBA-NS sensors influence the 
cells rate of progression through apoptosis. TEM results have shown that while some 
cells are undergoing autophagy or are apoptotic this is normal in the population of cells 
and also seen in untreated controls. 
Nuclear fragmentation measured by DAPI staining was used to track apoptosis 
progression. Results showed no significant change in progression of cells through 
apoptosis (condensation of chromatin and fragmentation) at any time point between the 
cells treated with nanoparticles and untreated controls (Figure 5.7). These results 
suggested that the sensors are suitable for measuring redox potential in HeLa cells 







Figure 5.7 Influence of MBA-NS (A), NQ-NS (B), and AQ-NS (C) on apoptosis 
progression rate following induction of apoptosis with 1µM staurosporine. 
Condensation of chromatin and nuclear fragmentation were assessed by DAPI staining 
and were shown not to be significantly different between the cells treated with 
nanoparticles. Data shows a summary of three. Error bars represent the standard 
deviation of three independent experiments. Student t-test was carried out between 

































5.2.2 Uptake and localisation of nanosensors 
 
The uptake of nanosensors by HeLa cells was confirmed by transmission electron 
microscopy (TEM) (Figure 5.8).  
TEM allows an electron beam to pass though the ultra-thin sample and interact with 
materials in the sample. This high resolution technique provides an opportunity to 
distinguish between organelles and establish which compartments of the cell the 




Figure 5.8. Transmission electron micrographs showing localisation of 
nanoparticles after uptake of AQ-NS, MBA-NS, NQ-NS by HeLa cells. 
Nanoparticles were identified  mainly in the cytoplasm. Cells were exposed to AQ-NS 
(A,B), MBA-NS (C,D) and NQ-NS (E, F) nanoparticles at 10 fM overnight; Untreated 
control (G, H) arrows are pointing at an artefact of TEM. Nanoparticles are revealed as 







Figure 5.8 shows that NQ-NS, AQ-NS and MBA-NS were taken up by the cells and 
were localised to the cytoplasm. These results indicated that sensors can be translocated 
to the cytoplasm as single particles or aggregates. Of a particular interest is the fact that 
the individual nanoparticles are residing mainly in the cytoplasm while some aggregates 
and alike are encapsulated by some form of vesicle.  
Artefacts of TEM staining which superficially resembled the sensors were sometimes 
seen. Examples are indicated by arrows in Figure 5.8H. These electron-dense structures 
were distinguished the nanoparticles by their irregular shape.   
In order to establish the percentage of cells which had taken up the nanosensors, 126 
and 47 TEM sections were analysed for uptake of AQ-NS and NQ-NS, respectively. 
68.3% of sections included AQ-NS and 58.8% of sections included NQ-NS (Figure 
5.9).  
 
Figure 5.9 Uptake of nanosensors (AQ-NS and NQ-NS). The bar-chart depicts the 
percent of sections with uptake of nanosensors (126 sections were counted for AQ-NS 
and 47 for NQ-NS).  
These data are in agreement with previously published work in Campbell’s lab that the 
incubation of cells with nanosensors using media without serum resulted in sensors 




























5.2.3  pH measurements in HeLa cells by MBA-NS 
From the selection of nanosensors used in this study, a unique feature of the MBA-NS 
was its ability to track changes at the intracellular environment’s prevailing pH, with a 
detection range between pH 6 and pH 9. Therefore the sensitivity of this method allows 
the detection of pH changes at a single cell level with three orders of magnitude 
resolution.  
The relationship between pH and apoptosis has been measured [160, 161]  and the 
measurement of an accurate redox potential requires the measurement of pH (this is 
often overlooked, or a steady-state pH is assumed) [102].  Here, the MBA-NS was used 
to gain precise understanding of the actual intracellular pH values and provide accurate 
redox potential values during apoptosis progression. 
Figure 5.10 shows a detailed scan of three cells in the field performed with 1 mm by 5 
mm steps in y and x axis, respectively. MBA-NS SERS spectra were acquired over 10 
seconds with 50% laser power. The intensity at 1500 cm-1 corresponding to high 
intensity pH-independent aromatic ring vibration allowed localisation of pH sensor 
within the field. Following the localisation of the pH sensor within the field 
quantification heat-maps were generated (Figure 5.10 and Figure 5.11) to allow 





Figure 5.10A Example of maps of redox potential (AQ-NS) and pH (MBA-NS) 
measurements in untreated control. A detail scan was performed with 1 mm by 5 mm 
steps in y and x axis respectively. Colour maps for redox potential measurements and 
pH were generated with MatLab script written by Dr Kate Fisher (Campbell Lab). The 
corresponding fields on the pictures below the colour maps indicate the field analysed. 
The shape of two windows differ due to x and y step size width and depth. SERS 





Figure 5.10B Example of maps of pH measurements with MBA-NS and redox 
potential measurements with AQ-NS in HeLa cells treated with staurosporine for 
120 minutes. A detail scan was performed with 1 mm by 5 mm steps in y and x axis 
respectively. Colour maps for redox potential measurements and pH were generated 
with MatLab script written by Dr Kate Fisher (Campbell Lab). The corresponding fields 
on the pictures below the colour maps indicate the field analysed. The shape of two 
windows differ due to x and y step size width and depth. SERS spectra were acquired 
over 10 s with 50% laser power. SERS spectra were acquired over 10 s with 50% laser 
power.  
 
Measurements of the intracellular pH via MBA-NS after induction of apoptosis with 
STS and unstimulated controls provided values which could be used for pH-adjusted 
redox potential calculations. The pH for each parameter was obtained from the relevant 
calibration curve and the associated error determined from the error in both the 
Lorentzian fit and the calibration curve  [162]. As determined from the calibration curve 
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the working range of the pH sensor is between pH 6.0 to pH 9.0. The curve fitting 
analysis took a weighted mean of the seven parameters using inverse weighting. This 
was done to minimise the effect of parameters with a large error. If 4 out of 7 
parameters of spectra were within the range, the spectra was taken further for analysis. 
The overall pH values then combined into a weighted average for each map.   
No significant difference in intracellular pH was observed between apoptotic cells and 
controls:  the mean values were 7.406 and 7.412 , respectively (Figure 5.12). In 
previous calculations of the redox potential, a constant value of 7.2 for pH was used, 
since this is considered to be a representative physiological pH. 
Mitochondria are critical facilitators of a apoptosis as a result apoptosis as a result of 
mitochondrial permeabilisation and cytochrome-c translocation [161]. To investigate 
the relationship between permeabilisation, pH and redox potential, Bongkrekic acid 
which inhibits mitochondrial permeability transition pore opening was used. 
Depolarisation of mitochondria following the treatment of staurosporine was again 
confirmed using TMRM (Figure 5.11).  
 
 
Figure 5.11 Mitochondrial membrane depolarisation measured with TMRM in 
HeLa cells untreated control and 20 minutes after triggering cell death by staurosporine.  
 
 
After pre-treatment of cells with BKA for 1 hour, a pH of 8.085 was recorded in non-
apoptotic samples (Figure 5.12), a significantly higher pH than BKA-free controls.  
However, following induction of apoptosis by STS in BKA treated cells for 30 minutes 
up to 59 minutes, a pH of 7.266 was observed, demonstrating a significant difference to 
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STS-free BKA treated control and suggesting a delay in apoptosis due to mitochondrial 
exclusion from the process. After this time point the discrepancy in the pH was minimal 
and not significant and allowed cells to progress further in apoptosis (Figure 5.12).  
 
 
Figure 5.12 Analysis of resting cytoplasmic pH in HeLa cells and change in pH 
throughout apoptosis measured by MBA-NS.  ** indicates significant difference of 
BKA treatment between samples measured by ANOVA (p=0.0016). # indicates 
significant difference between BKA only versus no STS treatment for all time points. 
*p>0.01 being statistically significant. 
 
Data from the pH that was stated as outwith the range of the sensor and marked acidic 
or basic, as appropriate showed an interesting trend. Individual maps showed that the 
percentage of basic spectra that were out of range, were higher in HeLa cells pretreated 
with Bongkrekic acid. Statistical sample size (n) was taken to be the number of 





5.2.4 Redox potential change in apoptotic HeLa cells 
Each nanosensor has its own range that it can measure within. The first sensor used in 
this study was NQ-NS, the half-wave potential of which is -283 mV and covers a range 
within normal physiological redox potentials from -344 mV to -194 mV. However, 
SERS spectra from NQ-NS in the cytoplasm of HeLa cells were fully reduced values of 
the sensor and it was difficult to depict the C=O stretch signal, thus preventing 
determination of the resting potential in the cytoplasm.  
As previously mentioned, pH values are important for the sensors since they involve 
proton exchange, so to accurately measure the redox potential, a value of the redox 
potential has to be pH adjusted. The Nernst equation shown below demonstrates the 
influence of pH change on the half-wave potential of the AQ-NS sensor, where m is the 
number of protons in the reaction. 



















𝐸 = 𝐸0 + 29.6 𝑙𝑜𝑔
[𝐴𝑄𝑜𝑥]
[𝐴𝑄𝑟𝑒𝑑]
− 59.2 𝑚𝑉 pH 
 
The MBA-NS pH probe allowed a table of reference time-resolved pH values to be 
calculated, allowing adjustment of the Nernst and subsequent redox potential values for 
the intracellular pH. The redox potential within HeLa cells, during the early stages (first 










Table 5.1 shows pH values measured with MBA-NS for each time point measured 
with and without BKA pre-treatment. Correction values for each time point are 
shown in mV.  
The spectra of AQ-NS show signals both at 1666 cm-1 (C=O stretching in oxidised 
conditions) and 1606cm-1 (constant C=C stretching in reduced and oxidised forms). It 
showed that the redox potential reported by AQ-NS in untreated HeLa cells is  
-362.8±8.7 mV at pH 7.412±0.27. 
After correcting for pH, no significant difference in redox potential was observed during 
the early timeframe of the apoptotic process (Figure 5.13). Whereas HeLa pre-treatment 
with BKA had a profound effect on the redox potential at the beginning of the process 
(FIGURE 5.13; HeLa BKA).  
  
Staurosporine 







No STS 7.412 -24.3492 8.085 -64.1235 
0-30 min 7.221 -13.0611 7.862 -50.9442 
30-60 min 7.396 -23.4036 7.266 -15.7206 
60-90 min 7.477 -28.1907 7.597 -35.2827 





Figure 5.13 Analysis of the resting cytoplasmic redox potential in HeLa cells and 
change in redox potential throughout apoptosis measured by AQ-NS. * indicates 
significant difference of BKA treatment between samples measured by ANOVA.  
 
Non-apoptotic BKA pre-treated samples demonstrated a mean value of -406.65±8.87 
mV. This value of the redox potential is covered by the detection range of the AQ-NS, 
with the lower limit of -450 mV. This observation confirms continuous dependence 
between pH and redox potential within the intracellular space. Initiation of apoptosis 
through STS causes prompt and significant transition of the redox potential towards a 
more oxidative state and reflects the importance of mitochondria in regulating the redox 
state. It is also important to note that BKA treatment promotes transient inhibitory 
effects on mitochondria, mirroring the data trends in Figure 5.12. 
Adjustment for pH provides a clearer insight into the redox potential dynamics, with 
consideration of the surrounding environment, and accurate quantitative assessment of 





5.3 Discussion  
This chapter investigated the correlation between redox potential and apoptosis in the 
single cell. For this purpose, a novel method established by the Campbell lab employing 
redox-responsive quinone-based nanosensors was used. The method offers a potentially 
more reliable alternative to fluorescence-based techniques, especially for the early 
events of apoptosis, due to more rapid response time and greater sensitivity. 
The results of this section can be summarised as follows:  
 Cytotoxicity studies were performed by introducing the NQ-NS, AQ-NS, and 
MBA-NS and monitoring the rate of apoptotic progression using previously 
established techniques. No significant difference was seen between the 
apoptotic progression at specific time points between nanosensor-treated and 
untreated cells.  
 Throughout the study on nanosensors it became apparent that the pH status of 
the compartment highly influences the redox status of the molecules and the 
Nernst equation parameters, and as a result the redox potential value is skewed. 
In this study the potential was initially calculated at a pH value of 7.2 which 
might not be correct for the apoptotic process as it was reported previously by 
other groups to change throughout the process. 
 Bongkrekic acid showed that changes of pH to more alkaline is crucial for 
protection of the cells from apoptosis. These changes happen prior to 
mitochondrial depolarisation. Upon mitochondrial depolarisation the pH 
becomes more acidic thus contributing towards a more oxidative environment 
and a rise in overall redox potential.  
AQ-NS with half-wave potential of -317 mV and the useful reporting range window is 
from -410 mV to -240 mV at pH 7.2 according to spectroelectrochemical investigation 
presented by Jiang et al. [98][138]. The AQ-NS half-wave potential is more negative 
than NQ-NS and is similar to NADPH which is -327 mV. Spectra from AQ-NS 
indicated that the resting cytoplasmic potential is approximately -362.8 mV (±8.7mV) 
after pH adjustment. Which is more reduced than values measured by GSH/GSSG 
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responsive GFP in HeLa cells, reported previously by Dooley et al [98] as their system 
showed basal redox potential of roGFP2 as -325mV.  
In the previous chapter, the redox potential of apoptotic cells was shown to be more 
oxidative when compared to untreated cells therefore the change in oxidation of reporter 
molecules after cells were stimulated with 1µM STS was investigated. Two 
simultaneous measurements were taken in parallel, the pH and the redox potential, 
using pH and redox nanosensors since this gives more insight into the processes that are 
measured as opposed to the redox potential measured only by roGFP. Thus measuring 
both the pH and redox potential quantitatively allows advancement towards 
understanding of the apoptotic process.  
Bongkrekic acid showed that changes of pH to more alkaline are crucial for the 
protection of cells from apoptosis. These changes happen prior to mitochondrial 
depolarisation. Upon mitochondrial depolarisation the pH becomes more acidic thus 
contributing towards a more oxidative environment and a rise in overall redox potential.  
In some forms of cancer, the increase in reactive oxygen species triggers the production 
of reducing equivalents, thus cancer cells may maintain a more reducing intracellular 
environment in general and a more alkaline intracellular pH (pHi) [21, 163, 164]. This 
may be consistent with the data from this study showing the potential measured by AQ-
NS nanosensors was at the reductive range of the nanosensor giving a value of steady 
state potential of -386.2 mV (Figure 5.13). This value indicates that the intracellular 
redox potential in the cytoplasm of HeLa cells is much more reducing than the ones 
reported previously for GSH/GSSG ratio measured by roGFP for these cells [101].   
Gutscher et al. reported that a five-fold increase in HeLa cell density contributes to a 
more reductive potential of GSH/GSSG measured by roGFP from -280 mV (1.6x104 
cells/cm2) to -320mV (when density 8x104 cells/cm2). The oxidative change in redox 
potential measured by the same roGFP was reported to shift from -290 mV (at ground 
state) to > -240mV after 3-4 hours of apoptosis. In the current study cells were kept at a 
constant density of approximately 1.5x104 cells/cm2.  
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The second aim of this chapter was to investigate whether single cell measurements are 
more accurate than the population level measurements made by flow cytometry. Indeed, 
this study shows that nanosensors are capable of indicating the redox potential and pH 
with subcellular resolution.  
One can argue that the limitation of this method is the uptake of the sensors by cells and 
their subsequent localisation within the cells. However, from a single cell analysis 
perspective this form of sensing the redox potential gives a high resolution, point 
approach to analysis in different regions of the cell. Previous data from the lab showed 
that nanosensors can be safely delivered to the cytoplasm, did not affect the viability nor 
cause an imbalance in the redox status of the cell. In serum-free conditioned media 
these sensors were reported to be taken up without capture in the endosomes by NIH-
3T3 fibroblasts [159]. Transmission Electron Micrographs of HeLa cells showed that 
nanosensors are not encapsulated in the vesicles. However, some of the micrographs are 
faint and typical cellular structures are not seen due to NS being very electron dense. 
 
Despite the observed oxidative change in potential in some of the experiments, it is very 
important to have a consistency in nanosensor delivery to make sure that they are in 
cellular structures desired and not entrapped in vesicles. Endosomal pH is much lower 
than the resting cytoplasmic pH, being 5 and 7.2, respectively. Some, but not all of the 
nanosensors were observed to be in endosomal structures; however this did not 
influence the readout of the values from cells. This might be of interest as maybe upon 
acidification of the cytoplasm sensors were taken up by vesicles. Therefore, it is 
important to incubate the cells in serum-free medium as this has been shown that serum-
free conditions does not promote the encapsulation of sensors in endosomal structures 
[99]. 
With recent technological advancements, single cell analysis has become a point of 
interest as heterogeneity is common between individual cells within the homogeneous 
tissue being it understanding of gene expression studies [165], or cell to cell 
communication [147]. Single cell analysis is viewed as an attractive means to better 
understand responses and communication between cells and then apply this to the 
population level [147]. One such example is cancer, where understanding of cell 
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diversity is crucial for targeted therapies against development, progression, and 
metastasis of the tumour mass.  
In summary, this chapter shows quantitative measurements of biomarkers, redox 
potential and pH, in live cells using SERS nanosensors. Moreover, redox potential was 
characterised at a single cell level with localised specificity at different time points of 
apoptotic process. This chapter demonstrates that the pH remains fairly stable 
throughout apoptosis triggered with staurosporine.  
Finally, the SERS method might represent an attractive monitoring of therapeutic 
intervention and could also be used in monitoring of the success of therapy progression 





Chapter 6  
Discussion and future work 
 
6.1 Summary of objectives and findings 
The intracellular redox potential plays important roles in determining cellular function 
and therefore its disruption may have adverse effects on cell function. The main 
objective of this thesis was to understand and measure redox potential change at the 
commencement and at the end of the apoptotic process and correlate these findings with 
biomarkers of programmed cell death to better understand the role of redox potential in 
programmed cell death. 
The aim was achieved as this work shows the importance of the redox potential change 
in apoptosis both at the high throughput cell by cell level (cell population) and low 
throughput (single cell) levels and correlates it with apoptotic events, particularly 
mitochondrial outer membrane permeabilisation as this event is considered a point of no 
return. However, the mechanisms such as ATP hydrolysis can promote mitochondrial 
membrane potential maintenance even after cytochrome c is released from the 
intermembrane space. Encompassed in these investigations is the determination of 
whether the redox potential changes are the cause or a consequence of the apoptotic 
process. It has been hypothesised that accumulation of harmful radicals and the 
consequent rise of redox potential above a critical threshold triggers apoptotic pathways 
[5].  
The first objective of this thesis was to generate a cell line that would enable redox 
potential to be investigated at a population level. HeLa cells were transfected with redox 
responsive green fluorescent protein (roGFP2) and selected on the basis of stable 
expression to create a monoclonal population. Apoptosis was triggered with a non-
oxidant, protein kinase inhibitor, staurosporine.    
The roGFP2 has been previously used in studies concerning measurements of 
intracellular redox status of GSH/GSSG [101, 109, 166]; however it was used for the 
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first time here to study redox potential in apoptotic cells. HeLa cells stably transfected 
with roGFP2, showed progression through apoptosis that was not significantly different 
from the process in non-transfected HeLa cells as measured by: nuclear fragmentation, 
mitochondrial depolarisation, and caspase-3 activity, highlighting the stability of the 
transfection. This demonstrated no significant alterations in the apoptosis machinery, 
and validated the in-house developed HeLa-roGFP2 cell line as a reliable model for 
studying the redox dynamics of HeLa cells.  
The high throughput flow cytometry multiparameter experiments described in Chapter 4 
depicted an overall trend in redox potential change in individual cells at the population 
level in the context of established apoptotic events. The data shows that cells 
undergoing staurosporine-induced cell death first expose phosphatidylserine, followed 
by mitochondrial depolarisation, caspase -3 and -7 activity and finally nuclear 
fragmentation. 
The role of reactive oxygen species in induction and apoptotic signalling has been a 
main focus of research when considering oxidative stress. This current study focused 
mainly on quantitative changes in redox potential, rather than levels of reactive oxygen 
species in the cells. Redox potential measured at the population level with HeLa-
roGFP2 showed that in cells undergoing apoptosis a significant change was observed 
after six hours post-induction. This suggested that the redox potential measured by 
roGFP2 changes after the depolarisation of mitochondria. 
Similarly, in Chapter 5 single cell level studies using quinone-based redox reactive 
molecules mounted onto gold nanospheres and spectra collected by SERS, showed that 
the redox potential change in the early stages of apoptosis was similar to changes 
observed in high-throughput studies. 
6.2 Correlation of environmental redox potential change and 
oxidative status of apoptosis  
The work in this thesis showed that the redox potential change in the light of stress 
response is a consequence of apoptotic events. Redox potential, measured by roGFP2, 
was found to be significantly different only after 6 hours of apoptosis (Chapter 4, Table 
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4.1). Furthermore, redox tracking via roGFP2 showed that phosphatidyl serine exposure 
precedes changes in redox potential. While roGFP2 is responsive to Grx1 activity and 
glutathione status in the cell, AQ-NS responds to the overall redox potential. Moreover, 
the correction for pH might have been substantial for the overall redox potential 
reported by AQ-NS, as 1 pH unit changes the redox by 59.1 mV [8]. Redox potential at 
1 hour of induced apoptosis was -300.1 mV as reported by roGFP2 at the population 
level and -353.5 mV reported from single cell analysis reported by AQ-NS sensors. The 
discrepancy of these findings might be due to the specificity of the two sensors, as they 
are measuring different parameters of the redox system. 
  
 
Figure 6.1 Summary view of key apoptotic events in HeLa cells and correlation 
with redox potential and pH. Events are ordered from left to right as they occur in the 
cell. Displayed are percent of cells at each stage of apoptosis with exposed 
phospohatidylserine (AxV +ve), polarised mitochondria (ΔΨm), activity of caspases 3 
and 7 (caspase 3/7), fragmented nucleus (nuclear fragmentation) and pH at given redox 
potential. Redox potential was measured by roGFP2 and AQ-NS. pH was measured by 
MBA-NS.  
 
As shown in the study by [76] Circu et al. the efflux of reduced glutathione from the 
adenocarcinoma epithelial cell line HT29 may play a significant role in driving 
apoptotic events, even though cells maintain a stable GSH/GSSG redox environment 
throughout apoptosis. Therefore, roGFP2, employed in the current study addressed the 
needs of the present experimental design. The roGFP2-Grx1 protein may be considered 
for future kinetic studies of redox potential once the signal quality problem in the 
oxidising range of potentials is resolved [140]. 
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In Chapter 5, where surface enhanced Raman spectroscopy and nanosensors were used 
to provide an analysis of redox and pH at a single cell level, every analysed cell was 
treated as an individual experiment. The SERS method enabled the measurement of the 
local properties of the cytoplasm of single living cells in the physiological milieu, by 
tracking nanoparticles within the cell with high spatial and temporal resolution, the local 
redox potential properties of the intracellular environment were measured in different 
locations within the cell. The signal acquired from SERS can be translated to reflect the 
redox potential of the cytoplasm in the vicinity of the nanosensor. The map of the redox 
potential and pH showed a diverse distribution of redox potential in a single cell. The 
pH-sensitive nanosensors, MBA-NS, have identified location-specific variation of the 
pH at a single cell level. This suggests that the intracellular milieu inside of the cell may 
differ dependent on the location. On the other hand it can also be assumed that the 
sensors have been distributed to the endosomal structures for transportation outside of 
the cell. As shown in Chapter 5, the data from TEM showed that the majority of sensors 
were in the cytoplasm, however a fraction of the cells showed encapsulation of the 
sensors in the endosomal structures (Chapter 5, Figure 5.8). 
6.3 Alkalisation causes reductive redox potential resulting in 
delay in apoptosis  
Due to the role of mitochondrial function in cellular metabolism and function, these 
structures have been of interest for a long time. Two of the key events in apoptosis that 
are connected to the mitochondria are: the release of cytochrome c and mitochondrial 
membrane depolarisation. Even though these two events were considered to be 
inseparable, some evidence exists that mitochondrial depolarisation does not 
immediately follow cytochrome c release. 
The results from the single cell experiments, presented in Chapter 5, showed that 
alkalisation of the cytoplasmic pH by bongkrekic acid resulted in a delay in the 
apoptotic processes, which is in line with the literature. Gottlieb et al. [134] showed that 
buffering with imidazole made the cytoplasmic pH more alkaline and protected Jurkat 
cells from cell death. This effect was achieved 60 minutes after induction of cell death 
by Fas ligand [145]. Meinsenholder et al. reported that the change in pH is linked to 
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Bcl-2 and the induction of caspase cascade and that both events preceded the 
acidification of the cytoplasm [145]. This study was conducted in CEM cells and cell 
death was induced by Fas antibody. Overexpression of Bcl-2 protected cells from 
acidification and halted phosphatidyl serine exposure. The same study showed that 
acidification is preceded by activation of the caspase cascade, since Z-VAD.fmk 
inhibited Fas-mediated acidification. 
Cellular apoptosis is a sequential process, in which biochemical events underlie 
morphological changes and allow progression of the cells through the apoptotic process. 
Chiu and Oleinick showed that in photodynamic therapy-induced apoptosis cytochrome 
c release into the cytosol precedes mitochondrial depolarisation, and somehow occurs 
independently of it [160]. However, the described study used JC-1 as a reporting tool 
for mitochondrial polarisation. This might be misleading as JC-1 has a long 
equilibration time. It would be interesting to measure the loss of the mitochondrial 
membrane potential (∆Ψm) with TMRM along with cytochrome c release from 
mitochondria. Such study showed that indeed the mitochondrial depolarisation is not an 
immediate consequence of cytochrome c release [167]. It would be of benefit to monitor 
cytochrome c redox status as this event has been reported to be one of the major 
hallmarks of early apoptosis preceding mitochondrial depolarisation, but it is not crucial 
for being a point of no return in the apoptotic process. However, the mechanism is not 
clearly understood [167, 168]. 
Cytochrome c release has been shown to be dependent on the depletion of reduced 
glutathione even in the occasion when the apoptosis was not an ultimate consequence of 
such event [56]. Similarly, Goldstein et al. showed that the release of cytochrome c 
from mitochondria precedes annexin V binding to the cell membrane [167]. This study 
also showed that the loss of mitochondrial membrane potential is a consequence of 
cytochrome c release however it is delayed and not immediate. In addition, the loss of 
∆Ψm, but not the cytochrome c release, has been shown to be dependent on caspase 
activity [167]. Both of these studies provide a mechanistic view of the critical events in 
apoptosis, but they do not consider the four key events at the same time in the same cell 
population. The work presented in Chapters 4 and 5 tracked of four key progression 
markers of apoptosis (PS exposure, Caspase-3/-7 activation, loss of ΔΨm and nuclear 
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fragmentation) along with simultaneous measurements of redox potential and pH 
change.  Furthermore, this informative data set was further enriched with intra-cellular 
pH measurement at a single cell resolution.  
Hence, this body of work provides a comprehensive reference list of redox potential 
values for the apoptosis stages and defines the sequence of events (Figure 6.1). Holistic 
understanding of the apoptotic process builds a solid foundation for the novel, i.e. 
redox-driven, development of therapies in cancer studies [169]. One of the hallmarks of 
cancer is the evasion of apoptosis, and thus cancer cells oscillate in a more reductive 
redox potential range together with more alkaline intracellular conditions, even though 
the extracellular environment is more acidic. Moreover, the microenvironment 
(including pH and pO2) has been shown to control proliferation, invasion, viability and 
metabolism of tumour cells [170]. This has been shown to promote cell survival and 
metastasis [171]. Such an approach of using redox cancer chemotherapeutics, together 
with knowledge of the redox potential in the tumour environment would prove 
beneficial in personalised, more effective treatment of cancer. Many used 
chemitherapeutics use s-glycosylation already as one of the redox target to induce cell 
death in cancer cells. Some of the available therapeutics prevent s-glycosylation of 
proteins thus inhibiting the production of reduced glutathione in the cell and in 
consequence inhibiting growth of cells and contributing to cell death. 
6.4 Loss of mitochondrial membrane polarisation and change 
in redox potential 
Chapters 3 and 4 focused on a kinetic analysis of key markers of progression through 
apoptosis. roGFP2 specifically senses changes in the Grx1-dependent redox status of 
the GSH/GSSG redox couple [101].  It also has significantly different electrochemical 
properties from those of NADPH and therefore it may not give a representative 
indication of the general intracellular redox potential.  Similarly, SERS enables 
quantitative measures of redox potential and pH. This gives more insight into processes 
that are being measured. Thus, measuring both pH and redox potential allows a greater 
understanding of apoptosis in quantitaive terms.  
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A study by Brauchle et al. studied Raman spectra and principal component analysis 
(PCA) to distinguish between necrosis and programmed cell death modalities. These 
studies could depict dynamic nuclear changes throughout apoptosis [150]. SERS was 
also employed in studies to distinguish early stages of apoptosis by using silver 
nanoparticles attached to the cell membrane [72].  
It would be interesting to investigate other forms of cell death, such as recently 
emerging and described ferroptosis [83]. As mentioned in the Chapter 1, section 1.4.2, 
ferroptosis is triggered by accumulation of ferrous ions that cause oxidative stress. This 
in turn triggers detoxification systems such as the glutathione redox cycle. However, not 
much is currently known about the redox status of the environment during this form of 
cell death. 
6.5 Single cell analysis and cell death delay by bongkrekic acid  
It has been shown that single cell measurements give a more accurate temporal and 
spatial resolution while these parameters might be lost at the population level. Single 
cell studies are more accurate for tracking of rapid, localised changes in the cell [172]. 
Lagadic-Gossman et al. showed that overexpression of Bcl-2 leads to inhibition of 
acidification [173], this was inhibited with cyclosporine and bongkrekic acid. 
Alkalisation of the cytoplasm, using bongkrekic acid, delays Bax translocation and its 
binding to the mitochondrial membrane through change in conformation of the Bax 
protein [174]. Clarification of the interaction mechanism between bongkrekic acid and 
Bax binding to mitochondria may explain why the delay in apoptosis occurs. The study 
of Khaled et al. showed that staurosporine induces alkalisation of pH and Bax activation 
upon withdrawal of IL-7 in T lymphocytes and in consequence apoptosis [175]. This 
might be due to the competitive activity of anti-apoptotic protein Bcl-2, which more 
alkaline conditions promote activity over Bax. It is reported that Bax oligomerisation 
forms a pore in the mitochondrial outer membrane [176][170]. Hence, Bax binding is 
considered as a mechanism for creating a gradient that is going to contribute towards 
depolarisation of the mitochondria.  In addition, it has been reported that the pH in 
cancer cells is more alkaline, which promotes regulation of cancer hallmarks, including 
higher proliferation rate and evasion of apoptosis [171]. In addition, extracellular 
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acidosis is one of the emerging hallmarks of cancer, and it is typical that a tumour has a 
reversed pH gradient (pHi > pHe) compared to healthy tissues [171, 177]. 
6.6 Redox potential change in apoptotic cells and correlation 
with metabolic disease 
During preliminary experiments investigating the redox potential in HeLa cells NQ-
based nanosensors were employed. Review of the results clearly showed that HeLa cells 
have a more reducing environment than the A549 cells and MCF-7 cell lines, which 
were originally used in Campbell’s lab to design NQ-based nanosensors. To ensure 
accurate detection of the redox status in HeLa cells AQ-based nanosensors were used, 
also developed in Campbell’s lab. The AQ-NS are able to detect changes in the redox 
status in more reducing environments, compared to NQ-NS. A difference in the default 
redox status between these cell-lines may be attributed to the fact that HeLa cells 
proliferate much faster than the A549 and MCF-7 cells as shown by other members of 
Campbell’s group. However, there might be other characteristics contributing to this 
difference, such as type of tumour and the proteome expression (MCF-7 cells lack 
caspase -3). This is in line with the literature, as the data from this thesis shows that 
HeLa cells treated with BKA showed delayed onset of apoptosis due to alkalisation of 
pHi. As shown in previously reported data, alkalisation of pH contributes to a higher 
rate of proliferation, result in a more reducing environment [171].  
By comparing the effects of bongkrekic acid on the mitochondrial depolarisation this 
study has shown that alkaline conditions protect cells from undergoing apoptosis. These 
findings are consistent with the literature, for example, Gottlieb et al. [178] 
demonstrated that acidification in Jurkat cells, a common model for acute T cell 
leukaemia, corresponds to an early feature of the apoptotic process. The same group has 
also shown that the acidification precedes DNA fragmentation. 
The current understanding of redox potential holds that it is one of the mediators of 
cellular behaviour and fate and acts by regulating cysteine switches of proteins [41]. 
However, it has also been suggested that even though a change in the redox potential is 
a consequence of apoptotic events it is irreversibly changing the cellular fate [179, 180]. 
This is consistent with the electrochemical theory of redox potential, where proteins 
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change their conformation at various redox potentials and are only activated when the 
environment is more oxidising [41]. For example, the endonuclease that is responsible 
for DNA digestion, DNase II, is reported to be activated at pH 6.8 in many cell lines 
and it can be switched on by more acidic pH [170].  
Acceleration of apoptosis in an oxidising environment was indirectly confirmed by the 
present study. Mitochondrial membrane depolarisation was inhibited by bongkrekic 
acid and then treated with staurosporine. HeLa-roGFP2 cells showed alkalinisation of 
the cytoplasm after being pretreated with bongkrekic acid prior to staurosporine 
treatment. This alkalinisation of pH has shown a delayed effect on the progression of 
apoptosis in these cells when compared to non-BKA pretreated control. These findings 
are in line with the literature, where BKA can be used to inhibit various agents inducing 
mitochondria-driven apoptosis [181]. 
Analysis of mitochondrial depolarisation and nuclear fragmentation, as markers of 
apoptosis, demonstrated a delay in apoptosis upon exposure to an alkaline environment. 
Therefore, findings from this study are supporting the electrochemical theory described 
above.  
6.7 Possible chemotherapeutic strategies based on redox 
potential measurements 
Staurosporine is a non-oxidant agent and it caused all apoptotic events but did not cause 
a significant increase in redox potential. It would be of benefit to look at the cells 
treated with other apoptosis inducing agents, to show whether or not the redox potential 
is affected by the stimulus itself. Future work might include the induction of apoptosis 
with appropriate concentrations of other agents such as NEM or a right concentration 
and time of exposure to H2O2 to analyse any differences between stimuli.  
Another well-known source of free radical generation used in cancer treatment is the 
use of radiation therapy. Furthermore, the SERS method has been used in 3D culture 




The redox potential has been shown to increase during apoptosis induced by H2O2 and 
this might be due to the oxidising nature of H2O2 and its ability to elevate ROS 
generation. A recent report by Thurlow et al. [183] described a new method of 
investigating protein disulfide formation. This methodology can be used to investigate 
the protein disulfide status of redox potential in the apoptosis process. In addition, in 
current study, the overall redox potential of the cell did not significantly change as the 
cells underwent apoptosis.  This might indicate that the oxidation of proteins at different 
potentials is independent of the oxidation status of the proteins within the cell. The 
results from this current study suggest that the oxidation of redox molecules might be 
due to the escape of electrons from the overall system of regulation of redox potential.  
It would be of interest to determine whether the rise in redox potential with apoptotic 
stimuli such as NEM would give the same effect as staurosporine. If so, this may 
suggest that the apoptotic process is dependent on the oxidation status as well as on 
several post-translational modifications of proteins involved in apoptosis including 
addition of a haem group to cytochrome c for example might be mutually important for 
the apoptotic activity of cytochrome c [183].  
The AQ-NS half-wave potential is more negative than NQ-NS and is similar to NADPH 
which is -327 mV. Spectra from AQ-NS indicated that the resting cytoplasmic potential 
is approximately -362.8 mV (±8.7mV) after pH adjustment. This is more reduced than 
values measured by GSH/GSSG responsive GFP in HeLa cells, reported previously by 
Dooley et al [98] as the system they reported showed a basal redox potential of roGFP2 
as -325mV, however this study assumed a pH value of 7.2.  
Since the redox potential in apoptotic cells was shown to be more oxidative when 
compared to untreated cells (Chapter 4 and Chapter 5), the change in oxidation of 
reporter molecules after cells were stimulated with staurosporine was investigated. The 
results showed that the pH has a tremendous effect on the redox potential change. Thus, 
measuring both pH and redox potential quantitatively improves understanding of the 
apoptotic process.  
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In some forms of cancer, the increase in reactive oxygen species triggers the production 
of reducing equivalents, thus cancer cells may maintain a more reducing intracellular 
environment in general[21, 163, 164]. This is consistent with the data from this study 
showing the potential measured by nanosensors was established by AQ-NS was at the 
reductive range of the nanosensor giving a value of steady state potential of -386.2 mV. 
This value indicates that the intracellular redox potential in the HeLa cells’ cytoplasm is 
much more reducing than the ones reported previously by roGFP for these cells.   
Work in this thesis also attempted to determine whether single cell measurements 
provide a valid tool for representation of the whole cell population. This has been 
achieved. The understanding of diversity of cells in a population may contribute 
towards elucidating disease development at a single cell level, potentially providing 
effective treatment approaches for diseases, such as metastatic cancer and aberrant 
development of diseases [147].  
Intracellular measurements with SERS methodologies including SERS-reporter as well 
as reporter-free SERS are of particular interest as new drug targets and delivery to 
pathogenic cells will be of crucial target to the pharmaceutical industry. This technique 
would allow localisation at the sub cellular level resolution.  
6.8 Points of consideration for future work 
In conclusion, the work in this thesis answered the fundamental question of redox status 
of the environment at different stages of apoptosis and correlated these findings with 
biomarkers of apoptosis in high throughput studies where a population of cells was 
measured, as well as in single cell analysis.  
Certain diseases such as cancer and neurodegenerative diseases suffer from alterations 
in metabolism, aberrant apoptosis as well as out of control pH and possibly redox 
potential, thus finding a link between those parameters would be an asset for further 
development of diagnostic tools. It is postulated that cancer cells maintain a more 
reducing environment due to their higher metabolic rate. This could affect the redox 
potential of the cell, making it more reducing.  
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Similarly, cell death processes, such as apoptosis or ferroptosis, and the status of redox 
are of interest and thus further investigation would be advantageous.  
Although one of the fundamental hallmarks of cancer is the evasion of cell death [77, 
78] in particular apoptosis it has been reported that ferroptosis, an emerging form of cell 
death, might play a crucial role in studies on cancer and lipid metabolism. One of the 
characteristic of ferroptosis is shrinkage of mitochondria as well as ROS generation [83] 
which might be of interest in further studies on redox potential. To date, this form of 
cell death has been vaguely characterised, however to date little is known about the 
exact values of redox potential in this type of cell death. While the ROS serve as 
mediators of signalling cascades and activation of proteins by oxidation, the redox 
potential status of the cell has been significantly neglected due to a lack of appropriate 
tools to measure this parameter. Moreover, as seen from this study, pH measurements 
are crucial for the redox potential measurements.  
Furthermore, shorter time points might be of benefit since observations of redox 
potential change in apoptotic cells might happen prior to the time scale that was used in 
this study. Investigation of redox potential at the 2 hour time point and addition of a 
reducing agent such as GSH or DTT to ‘rescue’ cells from programmed cell death and 
observe redox potential change would be of interest. Correlation of these changes with 
oxidation status of Bax, cytochrome c or caspases as well as knock out of those proteins 
would reveal possible correlations of redox status of those proteins at different stages of 
apoptosis.   
As for the use of nanosensors in further research, it would be of advantage to 
simultaneously determine the pH and redox potential, possible number or concentration 
of isolated exosomes in suspension or extracellular vesicles released from apoptotic 
cells. This would allow for real time monitoring and analysis of the sample on a particle 
by particle basis, and as such would allow the redox potential and pH to be monitored in 
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